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Abstract 
Multi-drug resistance is increasingly becoming a challenge to tuberculosis control 
programmes globally. Treatment of multi-drug resistance tuberculosis (MDR-TB) 
includes aminoglycoside antibiotics which are known to cause hearing loss. Ototoxicity 
monitoring services are often provided to patients undergoing treatment for MDR-TB for 
early detection of ototoxic hearing loss to facilitate alerting the patients and relevant 
medical staff about the presence and progression of any hearing loss. Previously, models 
of managing patients with MDR-TB required mandatory hospitalization for at least 6 
months. This made it relatively easy to monitor the hearing status of patients during their 
stay in the hospital. However, with recent introduction of policy guidelines that support 
management of patients with MDR-TB on an outpatients basis, ototoxicity monitoring for 
these patients will need to be reorganized to align with the new policy guidelines. The 
extent of the uptake of these services when patients are accessing them as outpatients is 
however, unknown. This study therefore aimed to describe the patterns of utilisation and 
explore the barriers and factors that facilitate the use of ototoxicity monitoring services 
when provided on an outpatient basis in the Cape Town Metropolitan area, Western 
Cape, South Africa.  
 
Methodology: This was a descriptive quantitative study that proceeded in two phases: 
Phase one used a retrospective record review to describe the pattern of use of the 
audiological services when provided on an outpatient basis. A total of 801 medical 
records of patients who were accessing MDR-TB care at a central TB hospital were 
reviewed.   Phase two explored factors that were facilitators of and barriers to the use of 
ototoxicity monitoring services. An exploratory survey methodology was used and the 
target population was adults with MDR-TB who were accessing treatment on an 
outpatient basis. Participants were sampled via a convenience sampling strategy. Patients 
attending MDR-TB treatment services at various health facilities were surveyed using a 
pretested and validated questionnaire developed for the purposes of the study. A total of 
74 participants were surveyed and the analysis of the questionnaire was conducted using 
descriptive statistics (frequency counts). Both descriptive and inferential statistical tests 
were used to analyse data collected in this study. 
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Results: A review of medical records in phase one of this study revealed that out of the 
first six standard hearing test appointments for patients being monitored for ototoxicity 
evaluated, a total of 76% patients attended  between 1-3 visits, (with 39.1% attending 
only the first appointment). Patients with normal hearing status as well as those who 
needed to travel greater distance to access services were more likely to not attend their 
scheduled appointment for ototoxicity monitoring.  In contrast, patients with pre-existing 
hearing loss, patients who developed hearing loss during treatment as well as the 
presence and development of disabling hearing loss were more likely to attend their 
scheduled appointment for ototoxicity monitoring. Phase two results showed that: close 
proximity to the healthcare facility, good interaction with nurses and having awareness of 
the ototoxic effects of the medication and therefore the need to monitor the hearing were 
positively associated with utilisation. Barriers identified were; having appointment 
clashes for co-existing ailments or grant processing, being hospitalized or the patient 
being sick (related to TB), and perceptions that normal hearing obviated the need for 
audiological monitoring services.   
  Conclusion: Ototoxicity monitoring services that are provided on an outpatient 
basis seem to be largely under-utilised among participants in this study as seen with the 
majority of the participants having minimal attendance (i.e. between 1-3 visits). 
Facilitators for utilisation of services were as follows: close proximity to the health 
facility, good interaction with the TB nurses and understanding the importance of 
monitoring the hearing due to the ototoxic effects of TB medication. Barriers reported by 
the participants included appointment clash for co-existing ailments or for grant 
processing and/ mixing up of dates, being hospitalized or the patient was sick and 
personal attitude- thinks the hearing is fine so does not need to have the hearing tested.  
Barriers to attendance need to be further analysed and addressed in order for the patients 
to maximise the utilisation of the services.  
Key words:  adherence, exploratory survey, MDR-TB, ototoxicity monitoring, 
service utilisation, tuberculosis 
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                                          Chapter One: Introduction  
              
Introduction: This chapter will contextualise the study by describing the global 
burden of tuberculosis (TB). The emergence of multi-drug resistant TB (MDR-TB) and 
its threat to TB control will be presented. Finally, the link between the treatment of 
MDR-TB and hearing loss and the need for monitoring will be outlined.  
Global Burden of TB 
         Despite advances in technological measures that yielded better diagnostic tools  and 
drug regimens for tuberculosis (TB) management, TB remains one of the major public 
health challenges of  the 21st century (World Health Organization [WHO], 2013). Global 
estimates of TB cases were reported to have a prevalence of 12 000 and an incidence of 8 
600 cases per 100 000 per year (WHO, 2013). As far back as 1991, WHO expressed great 
concern regarding the threat that TB posed in the public health sector.  
       The majority of reported TB cases are in South-East Asia (29%) (with India and 
China, accounting for 26% and 12% of these cases respectively), followed by Africa 
(27%) and West Pacific regions (19%) (WHO, 2013). In WHO’s opinion, a major 
concern regarding the African region is that it is not on track to reach the target of 
reducing the incidence and prevalence of TB; and deaths by one half between 1990 and 
2015 (WHO, 2013).  In addition, Africa’s rank of second in regions with high incidence 
TB cases suggests that significant effort is required to curb this pandemic.  
           In 2013, out of the 22 high-burden TB countries worldwide, nine were in the 
Africa (WHO, 2013). Furthermore, the African region is reported to have the highest 
proportion of individuals who are co-infected with TB and the human immunodeficiency 
virus (HIV) and more than 50% of these cases were in parts of Southern Africa (WHO, 
2013). Together, the continuing poverty and political instability in parts of the continent 
have inhibited progress in implementing effective TB control measures (Dye et al., 
2006).  
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              South Africa is considered to be one of the high burden TB countries and is 
currently ranked third among the 22 high-burden TB countries worldwide (WHO, 2013). 
The burden of TB in South Africa is estimated to be 400 000 – 600 000 with around 1000 
or more cases per 100 000 people in South Africa (WHO, 2013). This is considered to be 
a high prevalence rate especially when compared to about 10 per 100 000 population in 
parts of North America and Western Europe (WHO, 2013). The high occurrence of this 
disease in South Africa comes with a negative economic impact.  First, due to the 
magnitude of the problem, the inherent costs of treatment is high in terms of public health 
spending (TB Alliance, 2015), which will be discussed in more detail.  Second, the 
majority of the disease incidence and resultant deaths occur amongst the most 
economically active segment of the population (Murray 1996 as cited in WHO, 2000). 
These individuals are in most cases, the bread winner of the family therefore the loss of 
income has a direct impact at a family and societal level (WHO, 2000). 
  With TB at pandemic proportions, WHO recommendations regarding the 
treatment of all TB cases were adopted in South Africa in 1997 (Churchyard et al., 2014; 
Médecins Sans Frontières [MSF], 2011). The treatment entails using a form of a Direct 
Observed Treatment Short (DOTS) course  which has five distinctive elements namely 
political commitment with increased and sustained financing; case detection through 
quality-assured bacteriology; standardized treatment, with supervision and patient 
support; an effective drug supply and management system and last, monitoring and 
evaluation system, and impact measurement. Direct observation of treatment under the 
supervision of a healthcare worker is primarily associated with DOTS (WHO, 2010).  
Two primary aims of DOTS are to ensure completion of treatment and a cure for patients 
with TB; and second, to prevent drug resistance from developing in the community 
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MDR-TB 
          The primary cause of MDR-TB is due to inappropriate treatment (MSF, 2011). 
WHO (2013) stated that inappropriate or incorrect use of anti-TB drugs, or use of poor 
quality medicines, can all cause drug resistance. Most of the medication has undesirable 
side effects to the patients such as unexplained fever, feeling weak as well as blurred 
vision (MSF, 2011). Treatment for drug-resistant TB is longer and associated with more 
significant side-effects than drug susceptible TB (Njuguna, 2013) which may lead to 
some patients discontinuing treatment (MSF, 2011).  
           MDR-TB is described as a form of TB caused by bacteria that does not respond to, 
at least, isoniazid and rifampicin, the two most powerful, first-line anti-TB drugs (WHO, 
2013). With more than 450 000 new cases reported worldwide in 2012, MDR-TB is 
likely to put a strain on TB control programmes globally (Gandhi et al., 2010; WHO, 
2013). In 2012, an estimated 450 000 people developed MDR-TB globally. An increase 
of 42% of MDR-TB cases was also seen between 2011 and 2012 and the largest increase 
was in India, South Africa and Ukraine (WHO, 2013). It is estimated that about 9% of 
MDR-TB cases had extreme-drug resistant TB (XDR-TB) (WHO, 2013). Prevalence of 
MDR-TB was estimated to be 3.6% (95% CI 2.1%-5.1%) amongst new TB cases and up 
to 20.2% (95% CI 13.3%-27.2%) in previously treated MDR-TB cases in the same year 
(WHO, 2013).         
       The number of MDR-TB patients is on the rise in South Africa (WHO, 2013). In 
2008/2009 a survey was conducted by MSF, the City of Cape Town and National Health 
Laboratory Services (NHLS) in two sites. In Khayelitsha, an informal settlement area in 
Cape Town, 5.2% of new TB cases and 11.1% of previously treated TB cases were due to 
rifampicin-resistant strains (Cox et al., 2010). In 2012 an escalation was noted with about 
15,400 MDR-TB cases that were diagnosed in South Africa; 1.8% of new TB cases and 
6.7% of recurrent cases have MDR-TB (WHO, 2013). Hence, an estimated increase of 
MDR-TB cases is expected to continue.  
        The concern regarding an increase of patients who are diagnosed with MDR-TB is 
because MDR-TB treatment involves the use of a drug regimen (second-line drugs) that 
contains aminoglycoside antibiotics. These are known to be ototoxic in nature and can 
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lead to hearing loss as one of the side effects (Selimoglu, 2007). Aminoglycosides are 
commonly prescribed antibiotics used for treatment of life threatening illness  such as  
gram negative infections and MDR-TB (MSF, 2011). This group of drugs is known to 
have the potential to  cause toxic damage to both the kidney and the inner ear (Huth, 
Ricci & Cheng, 2011). According to Huth et al. (2011), renal toxicity is potentially 
reversible but the effects are permanent in the ear. Kanamycin and amikacin are mainly 
cochleotoxic whereas streptomycin and gentamicin are predominantly vestibulotoxic 
(Huth, et al., 2011). In South Africa, kanamycin is one of the drugs that forms part of 
second-line TB regimen (Department of Health, 2011) despite recommendations that the 
drug should be made obsolete due to its toxicity (Garcia-Prats, Donald, Hesseling & 
Schaaf, 2013).  
 Popularity of aminoglycoside use in the developing world is due to its low cost 
and powerful antibacterial activities, outrivaling more expensive antibiotics with less 
severe side effects (Huth et al., 2011). As a result, the incidence of aminoglycoside 
ototoxicity in developing countries is likely to be higher in comparison to the 
industrialized world. Furthermore, in the developing world monitoring for serum levels 
or for toxicity is less likely  (Huth et al., 2011). In South Africa, MDR-TB prevalence is 
high in HIV positive population (Padarath & Fonn, 2010; World Health Assembly, 1991) 
and highly active antiretroviral therapy (HAART) and ototoxic MDR-TB drugs are given 
simultaneously which compounds the potential for ototoxicity (Harris, Peer & Fagan, 
2012; Jacobs & Ross, 2012). HAART drugs are thought to be ototoxic and moreover, 
individuals with HIV are at a greater risk of contracting opportunistic central nervous 
system infections (Harris, Peer, et al., 2012; Khoza-Shangase, 2010). Jacobs and Ross 
(2012) conducted a study in Durban, South Africa on the adverse effects of MDR-TB 
treatment on patients. Adverse events were significantly more common in patients who 
were HIV positive than in patients who were HIV negative with regard to peripheral 
neuropathy, psychosis and confusion, hearing loss and thyroid disease.  
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Physiology and Pathophysiology of Aminoglycosides Ototoxicity 
An ototoxic effect within the class of aminoglycoside drugs was first documented 
with streptomycin which was introduced in 1940 to treat tuberculosis (Hinshaw & 
Feldman, 1945). After systemic administration, aminoglycosides are detected in the 
cochlea within minutes (Huth et al., 2011). Based on the cochlear structures, entry of 
aminoglycosides into the inner ear suggests a complex uptake mechanism. Both 
endocytosis and transport through ion channels are proposed to mediate aminoglycosides 
uptake into sensory hair cells (Huth et al., 2011). Hashino and Shero (1995) observed 
kanamycin in intracellular vesicles 27 hours after systemic injection in chicken (Hashino 
& Shero, 1995 as cited in Huth et al., 2011). These findings were interpreted as evidence 
for endocytosis as mechanism of aminoglycoside uptake as the vesicle membranes 
contained cationic ferritin, a membrane bound marker (Hashino & Shero, 1995).  
In their study, Qing and Mao-Ling (2009) found that kanamycin induced a major 
loss of outer hair cells but not of inner hair cells. Thus all studies to date suggest that first 
the outer hair cells is preferentially and irreversibly destroyed by aminoglycosides and 
second after prolonged treatment the inner hair cells and finally the spiral ganglion 
neurons are damaged. In addition,  the ototoxicity of a number of aminoglycosides on 
outer hair cells in cochlear cultures using scanning and transmission electron microscopy 
(SEM and TEM) was investigated and found that ototoxicity order was: 
neomycin>gentamicin>dihydrostreptomycin>amikacin (Qing & Mao-Ling, 2009). The 
molecular mechanism of aminoglycoside ototoxicity on the outer hair cells has been 
proposed by Williams et al (as cited in Qing and Mao-Ling, 2009) to be: 1) reversible 
binding of the aminoglycoside in competition with calcium to the plasm membrane, 2) 
energy-dependent uptake of the drug (similar to polyamine transport). However, recent 
studies by Basile et al (as cited in Qing and Mao-Ling, 2009) demonstrate that 
aminoglycoside induced ototoxicity is mediated by the polyamine site of the NMDA 
receptor. 
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Similar to cisplatin ototoxicity, various inner ear cell-types are thus affected by 
aminoglycoside treatment with the cochlear and vestibular hair cells and neurons being 
the most vulnerable to cellular degeneration. The degeneration tends to begin at the basal 
coil and extend apically thereby affecting the higher frequencies first (Tsuji et al, 2000). 
These drugs tend to cause permanent, irreversible damage which profoundly impacts the 
patient. In order to detect the hearing loss early, one way to manage it is to monitor the 
hearing regularly  (i.e. ototoxicity monitoring).  
Ototoxicity and Quality of Life 
While not focussed on the aetiology of hearing loss, Dalton et al., (2003) explored 
its severity on the quality of life in a large population-based longitudinal study. 
Communication difficulties and health-related quality of life were assessed. Their 
findings showed that the severity of hearing loss was significantly associated with having 
a hearing handicap and with self-reported communication difficulties, therefore reducing 
the quality of life in older adults (Dalton et al., 2003). These findings suggest that the 
worse the hearing loss is, the greater the impact on the quality of life, and most 
aminoglycoside-linked hearing loss tend to yield a severe or profound hearing loss 
(Harris, Peer, et al., 2012). Patients can therefore be prepared for the possible progression 
of the hearing loss, receive counselling and rehabilitation in order to try to ameliorate the 
expected poor quality of life and issues related to hearing loss. 
Tuberculosis (TB) patients have not only medical but also social problems related 
to their illness, which may influence their motivation for the completion of treatment 
(Karyadi et al., 2002). Their study investigated the social aspects of patients with TB in 
an urban area of Jakarta, Indonesia. The findings showed that most TB patients had poor 
nutritional status and lived in crowded environments. They faced joblessness and 
negative attitudes from their neighbours and relatives. A few of the patients were afraid 
that they would not find a partner; others said that their diseases impaired their marriages. 
In general, patients were supported by their families, both financially and socially. The 
findings therefore suggested that priority should be given to developing programs aimed 
at strengthening the family support of TB patients (Karyadi et al., 2002). 
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In light of the impact on the quality of life due to ototoxicity, monitoring services 
are therefore specified as necessary in the American Speech-Language and Hearing 
Association [ASHA] (1994) guidelines for patients who are on TB treatment that includes 
a regimen containing aminoglycosides. In South Africa, it would appear that more 
emphasis has been placed on treating MDR-TB than on monitoring hearing. For example, 
North West province has 100% DOTS coverage (Tumbo & Ogunbanjo, 2011); and yet  
there is still a heavy concentration of ototoxicity monitoring services at tertiary, urban 
hospitals and few or no services available in smaller facilities (Department of Health, 
2002; Harris, Peer, et al., 2012). The increase in the number of patients with MDR-TB in 
South Africa would also suggest that the greater the demand will be for ototoxicity 
monitoring services as a public health priority. The literature review which follows will 
therefore further explore the role of audiological services within an MDR-TB programme 
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Chapter Two: Literature Review 
Introduction: This chapter will start with a critical review of the literature related 
to studies investigating utilisation of services aimed at monitoring treatment side effects 
(including ototoxicity). The role of audiological services within MDR-TB programmes as 
well as an overview of what the ototoxicity monitoring programme within an MDR-TB 
programme entails will also be described. The importance of adherence to an ototoxicity 
monitoring programme will be highlighted. The chapter will conclude with a discussion 
on facilitators and barriers to utilisation of services aimed at monitoring treatment side 
effects using the WHO five dimensions framework.  
Prevalence of Ototoxic Hearing Loss  
Ototoxicity is defined as ‘the permanent auditory threshold shift as a result of 
irrevocable loss of outer hair cells and to some degree, inner hair cells as well’ in the 
cochlea due to exposure to drugs or chemical agents (Schacht, 2004, p. 94). Mudd, 
Edmund, Glatz, Campbell and Rybak (2012) stated that approximately 10% of people 
taking aminoglycoside antibiotics experience ototoxicity, although up to 33% have been 
reported in adult patients (Schacht, 1998 as cited in Khoza-Shangase et al., 2009). 
Ototoxicity following aminoglycoside treatment for MDR-TB, is a significant problem 
and has been reported to be an adverse reaction that occurs in 6-18% of patients (Duggal 
& Sarkar, 2007; Khoza-Shangase, Mupawose & Mlangeni, 2009). South African 
researchers have not only suggested a considerably higher occurrence of ototoxic hearing 
loss, but indicated that co-morbidity with HIV increases the risk (Harris, Bardien, et al., 
2012). A study by Harris, Bardien, et al. (2012) showed that MDR-TB patients who are 
HIV positive are at much higher risk of hearing loss than those who are HIV negative. A 
prospective cohort study was conducted of 151 MDR-TB patients with normal hearing 
and middle ear status at baseline at Brooklyn Chest Hospital in Cape Town. Their results 
showed that 87 (58%) of all participants developed high-frequency hearing loss. Out of 
the 86 (57%) HIV-positive patients, (60/86; 70%) were more likely to develop hearing 
loss their HIV-negative counterparts (27/65; 42%) (Harris, Bardien, et al., 2012). The 
South African data regarding the prevalence could be higher because of the different pure 
tone averages (PTA) that can be used to determine ototoxic hearing loss. A standard three 
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frequency PTA versus high frequency PTA, for example, can be used. The high 
occurrence of hearing loss noted in the South African results therefore motivates for 
comprehensive services in terms of screening, diagnosis and management of hearing loss.  
Impact of Ototoxic Hearing Loss  
   Regardless of the aetiology of acquired hearing loss, the impact can be profound 
and affect all areas of life (Khoza-Shangase et al., 2009). For example, in a large scale 
study of hearing impaired adults, Tambs (2004) showed that there was a moderate but 
clear effect of hearing impairment on measures of anxiety, depression, self-esteem and 
well-being, and that this was more pronounced in the young and middle-aged population. 
Brust et al. (2013) focused on patients receiving MDR-TB treatment who developed 
hearing loss. They found that moderate and severe irreversible hearing loss was a 
devastating side effect of aminoglycoside therapy. Njuguna (2013) also conducted a 
retrospective study on MDR-TB patients in Cape Town, and concluded that hearing loss 
at baseline and during treatment occurred frequently 47 (35.9%) and was often severe. 
The impact of ototoxicity on quality of life often leads to an inability to hear 
conversations, or vestibular symptoms, which may cause individuals to cease 
participating in their usual activities thereby impairing well-being (Weiss, 2013). 
Disabling hearing impairment, which can also be a result of ototoxicity, has a 
profound impact on interpersonal communication, psychosocial well-being, quality of life 
and economic independence at any age (Olusanya, Neumann & Saunders, 2014). WHO 
defined “disabling” hearing loss as a permanent unaided hearing loss – in the better ear 
and averaged over frequencies of 0.5, 1, 2 and 4 kilohertz (kHz) – of more than 40 
decibels (dB) in adults and 30 dB in children (WHO, 2014). According to the World 
Health Organization’s estimates, the number of people with such impairment increased 
from 42 million in 1985 to about 360 million in 2011. Olusanya et al. (2014) stated that 
in adulthood, disabling hearing loss can lead to embarrassment, loneliness, social 
isolation and stigmatization, prejudice, abuse, psychiatric disturbance, depression, 
difficulties in relationships with partners and children, restricted career choices, 
occupational stress and relatively low earnings. Although hearing disability is usually 
experienced over a lifetime, 1–10 about half of the incidence of hearing impairment in all 
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age groups could probably be avoided via known and proven methods (Olusanya et al., 
2014). 
Ototoxicity Monitoring during MDR-TB Treatment 
With descriptions of the ototoxic potential of aminoglycoside drugs published 
shortly after they were first introduced in the 1940s (Huth et al., 2011; WHO, 2014), one 
would expect extensive monitoring and management efforts to be implemented; or indeed 
the drugs to have been withdrawn from use (Garcia-Prats et al., 2013). Durrant et al. 
(2009) stated that ototoxicity monitoring expresses the principles of early identification 
and early intervention in order to manage the effects of hearing loss on the quality of life 
of an individual. Therefore, one of the roles of audiological services within the broad TB 
programme is to provide ototoxicity monitoring to patients undergoing MDR-TB 
treatment in order to detect early cochlear and/ or vestibular damage (Duggal & Sarkar, 
2007). The monitoring process involves having the hearing or patient’s report of 
vestibular complaints being monitored frequently, for example, on a monthly basis for the 
duration of the MDR-TB treatment (Duggal & Sarkar, 2007). Other roles include 
reporting and advising the health care professional and patient of pre-existing risks and 
hearing loss occurrence, allowing changes in treatment and most importantly 
rehabilitation of the loss (Durrant et al., 2009). Once a hearing loss has been detected the 
focus thus needs to move from monitoring to treatment and rehabilitation.  
Ototoxicity monitoring involves the scheduled, repeated use of hearing test on an 
individual over time to make decisions about the management of a condition (Dinnes, 
Hewison, Altman & Deeks, 2012). MDR-TB requires prolonged treatment of up to 18 to 
24 months (Duggal & Sarkar, 2007; TB Alliance, 2015). Monitoring is recommended 
especially in the first six months where injectable drugs such as kanamycin are 
administered and also six months after stopping the injectable treatment, therefore the 
monitoring period is extended and a greater need for adherence is thus required (Brust et 
al., 2014; Harris, Peer, et al., 2012). In an MDR-TB context, ototoxicity monitoring 
services are aimed mainly at patients who are on a treatment regimen that includes 
aminoglycosides such as kanamycin (Durrant et al., 2009). Ideally, the services should be 
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available where TB treatment occurs, as a way of increasing access to the health care 
service (MSF, 2011).  
According to Durrant and colleagues (2009), only the audiologist is endowed by 
the training to achieve both objectives of the ototoxicity programme through 
identification and diagnosis and rehabilitation of ototoxicity hearing loss and usually 
provides the services in a clinic or hospital setting. However, in a developing world 
context, due to the shortage of audiologists, ototoxicity monitoring can be performed by a 
non-audiologist who is trained in audiometric procedures, for example, a nurse (Durrant 
et al., 2009) under the regular supervision from an audiologist. The non-audiologist could 
conduct the actual hearing screening and identification whilst the audiologist manages the 
programme (i.e. quality assurance) and the interventions.  
There are guidelines available for monitoring ototoxicity such as the ASHA 
(1994) guidelines. Currently, there are no guidelines specific to South Africa. It would be 
ideal to have the procedures tailor-made for South Africa, with its unique context in 
mind. However, in the Western Cape Province, guidelines are being developed (C. 
Rogers, personal communication, December 6, 2013, K. Jacobs, personal 
communication, February 9, 2015). Duggal and Sarkar (2007) and Durrant et al. (2009) 
outlined the following recommended strategies for ototoxicity monitoring: 
1. A baseline audiogram is completed in order to establish if there is any risk factor 
or pre-existing hearing loss present and should be conducted within 72 hours of 
drug administration. It also permits comparison to the results of subsequent 
monitoring tests. All baseline testing should be completed prior to any ototoxic 
drug administration where possible, if not, within two days of drug administration 
especially with chemotherapy because of the fast effects of the drugs (Duggal & 
Sarkar, 2007). Baseline testing should be comprehensive and include pure tone 
thresholds in the conventional frequency range and high frequency range, 
tympanometry, speech audiometry and otoacoustic emissions. High frequency 
audiometry from 10 kHz to 16 kHz is the most sensitive test to ototoxicity 
followed by audiometric frequencies from 3 kHz to 8 kHz then 250Hz to 2 kHz 
being the least sensitive and last acoustic reflex thresholds.  
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2. Serial audiograms are used to detect changes in pure tone thresholds. The 
intervals for performing the hearing tests are determined by the feasibility in the 
different clinical contexts. Ideally for aminoglycoside antibiotics, monitoring 
should be conducted weekly or bi-weekly for the duration of the treatment 
(Duggal & Sarkar, 2007). 
3. To classify a significant change in hearing due to the development of ototoxic 
hearing loss, ASHA (1994) guidelines suggest using the following criteria: a 
significant hearing threshold change is defined as a 10 dB HL change in two 
consecutive frequencies, a change of greater than 20 dB HL in any one frequency, 
or an absence of response at 3 consecutive test frequencies in which responses 
were previously present and this is across the 250Hz to 8 kHz frequency range 
(Durrant et al., 2009). Both high frequency audiometry and OAEs are more 
sensitive than conventional audiometry and can detect hearing loss before 
conventional audiometry detects it (Durrant et al., 2009). However, in South 
Africa high frequency audiometry is rarely used because the equipment is 
expensive and less portable compared to OAEs (Khoza-Shangase, 2011). 
4. Ideally, an exit audiogram will then be completed when the patient leaves or 
completes the treatment. However, because ototoxic hearing loss can occur up to 
six months after completing treatment, post-treatment evaluation is required to 
ensure that the hearing has stabilized (Durrant et al., 2009; Harris, Peer, et al., 
2012; Huth et al., 2011).   
 
Decentralisation of Management of MDR-TB 
Prior to late 2011, national policy guidelines on the management of MDR-TB 
mandated that all MDR-TB patients be initiated on treatment only after they had been 
admitted to the country's few specialised TB hospitals (Department of Health, 2011). 
However, due to limited bed capacity in these TB hospitals most patients faced long 
waiting periods before they could start their MDR-TB treatment. For instance, in 2010 
alone almost 7,400 cases of MDR-TB were diagnosed from a number of provinces in the 
country, and these new cases far outstripped available bed capacity in these facilities 
(Department of Health, 2011).  
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Since patients were treated on an inpatient basis prior to 2011, ototoxicity 
monitoring services for MDR-TB patients were therefore also provided mainly at TB 
hospitals. Patients often stayed in hospital for approximately 6 months which was ideal 
for ototoxicity monitoring because they could be monitored for the entire duration that 
they were being treated with aminoglycosides. However, policy on the management of 
drug-resistant TB underwent some extensive review. In August 2011, the Department of 
Health released new policy guidelines on the management of MDR-TB, which prescribed 
the decentralisation of management of MDR-TB (Department of Health, 2011).  The 
primary objectives of this new management model included improving MDR-TB case 
detection, improving treatment outcomes and also decreasing MDR-TB transmission 
(MSF, 2011). This meant that MDR-TB patients will only be admitted in the hospital 
only if it is clinically indicated, namely in the case of very ill patients, who comprise 
roughly 10% of the MDR cases (Department of Health, 2011, TB Alliance, 2015). 
Primary health care doctors now had the responsibility to initiate treatment and review 
monthly in local clinics. The daily DOTS and nurse management were to be conducted in 
the clinics as well as the integration with HAART provision. In addition, individual 
counselling, home visits, support groups, social worker support and audiometry screening 
services were to be conducted locally (MSF, 2011).  
 The provinces of KwaZulu-Natal and Western Cape were the first to adopt the 
decentralised or community-based MDR-TB treatment model which allowed patients to 
access MDR-TB treatment almost 30 days earlier than in the hospital-based system 
(Integrated Regional Information Networks, 2012). Treatment in the community 
permitted MDR-TB patients to be treated as outpatients. The implications of 
decentralisation of MDR-TB management regarding ototoxicity monitoring then meant 
that services will also be provided locally and not only at the tertiary hospitals (MSF, 
2011).  
The Western Cape, where the current study was conducted, is geographically, the 
fourth largest province in South Africa The population for the Western Cape for 2010 is 
estimated at 5.22 million people and represents approximately 10% of the total national 
population. The population is relatively young with 56.21% of the regional population 
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being younger than 30 years of age. Furthermore, approximately 51.9% of the population 
is female. According to the most recent population census the coloured demographic 
group represents more than 50% of the total population of the Western Cape; this is 
followed by the Black, White and Asian demographic. In the Metro District the PHC 
utilisation rate correlates with the daily migration of employed persons who seek some 
health services close to the places of employment, the unemployment rate, household 
income and modes of transport. 
Adherence to Monitoring Services 
The success of monitoring depends on adherence among other factors. Adherence 
to prescribed therapies is a key factor in maintaining health in individuals with chronic 
illness (Sabati, Snyder, Edin-Stibbe, Lindgren & Finkelstein, 2001). Adherence is defined 
as ‘the degree to which an individual follows a health related recommendation’ (Shapiro 
& Shapiro, 2010, p. 324). The term adherence is preferred to compliance as it suggests 
active participation from the patient; whereas compliance implies a passive role (Shapiro 
& Shapiro, 2010). One therefore cannot always assume that patients will follow 
recommendations for management, even for potentially life-threatening diseases. One 
South African study conducted in KwaZulu Natal by Govender and Mash (2009) found 
that over one third of patients (34%) did not adhere to TB treatment. Factors associated 
with non-adherence included travel time and the relationship with TB nurses (Govender 
& Mash, 2009). The non-adherers may therefore more likely to become MDR-TB 
patients due to the lack of adherence.  
In the United States, non-adherence to breast cancer medication has been proven 
to negatively impact the health system, causing  125 000 deaths annually and resulting in 
between 10-23% of hospital and nursing home admissions (Moore, 2012). It is known 
that drug resistant infections are on the increase and non-adherence to medical treatment 
has a role to play in this.  The cost of non-adherence to drug-resistant infectious diseases 
was estimated to be between US$100 and 200 million in the United States alone per year 
(Rapoff, 2010). Thus, non-adherence also affects the cost-effectiveness of medical care 
and the clinical decisions that need to be made (Rapoff, 2010). Given the magnitude of 
non-adherence associated issues in a well-resourced country, management of adherence 
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issues in treatment programmes should be a key focus in developing countries such as 
South Africa. While the effects of non-adherence to ototoxicity monitoring services are 
not fatal, they certainly can negatively impact the health and well-being of patients 
should progressive, potentially, severe to profound hearing loss not be identified and 
managed appropriately.  
Patient adherence is required during the treatment of MDR TB in order to fully 
benefit from the ototoxicity monitoring services where patients need to undergo a hearing 
test bi-weekly or monthly (Duggal & Sarkar, 2007). However, no information regarding 
adherence to the monitoring protocol was available in the two facilities in which the 
current study was conducted; although there were perceptions that attendance at the 
audiology services was sub-optimal. Knowledge regarding utilisation of services could 
become the foundation for programme evaluation and planning, thus this study was 
conceptualised.  The next section will discuss some of the known barriers and facilitators 
to the success of monitoring programmes. 
One of the obstacles to ensuring that monitoring services are effective is a lack of 
a comprehensive and holistic understanding of barriers to, and facilitators of, treatment 
adherence. A systematic review of qualitative studies investigating adherence to 
preventative and curative TB on patients, caregivers or health care providers was 
conducted by Munro et al. (2007). The authors concluded that a wide range of interacting 
factors impact on treatment-taking behaviour and patient behaviour may change during 
the course of the treatment (Munro et al., 2007). More patient-centred interventions are 
therefore needed to improve treatment adherence (Munro et al., 2007).  
WHO (2014) stated that there are five interactive dimensions that affect 
adherence in healthcare service utilisation. These five dimensions are: health care team 
and system-related factors, social/economic-related factors, patient related factors, 
condition-related factors and therapy-related factors (WHO, 2014). A review of literature 
pertaining to monitoring other chronic conditions, will give insight into some of the 
issues that affect the use of services in a monitoring system. These will be framed 
according to the five WHO dimensions which will be applied to ototoxicity monitoring as 
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there is little or no available literature on the topic. Identifying potential barriers to 
adherence and implementing intervention strategies to enhance adherence, will thereby 
improve clinical outcomes (Moore, 2012).  
  Factors that Influence Utilisation of Health Services 
Health Care Team and System-Related Factors 
a. Logistics.  The first factor that impacts utilisation is the physical distance and 
time taken to reach the health care facility. Freitas, Tura, Costa and Duarte 
(2012) stated that the proximity of health care services can be predictive of 
adherence in a population-based breast cancer screening programme. In the 
Tshwane region of the Gauteng province, South Africa, three community 
health care centres were the subject of a study by Nteta et al. (2010) on the 
utilisation of primary health care services. Their findings showed that the 
facilities were accessible to most participants who lived within 5 km or 
travelled 30 minutes or less to such a clinic. By making health care services 
accessible, this has helped to improve the utilisation rate of the services as 
individuals now travel shorter distances to health care centres (Nteta et al., 
2010). Based on this reasoning, the proximity of the ototoxicity monitoring 
services (in this case, the area from which a patient is referred) was expected 
to be a facilitator to the use of these services. However, TB patients are often 
very ill, especially when first diagnosed (TB Alliance, 2015) so this patient 
population could be different from others who use local facilities for routine 
purposes such as immunisation or maintenance of chronic conditions such as 
hypertension.  
b. Waiting period within the health care system. The time taken for an 
individual from inclusion in the MDR-TB programme to the first audiologic 
test was explored in this study. Nkosi et al. (2013) found that a considerable 
number of MDR-TB patients deceased in the interval between diagnosis and 
referral, thereby highlighting the importance of a stringent, timely and 
effective referral system for this extremely vulnerable patient group. The 
above mentioned external variables are indeed important in bringing about 
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adherence to healthcare service utilisation but if a dysfunctional health care 
system is in place it renders them inadequate. 
c. Health promotion. Health professionals can disseminate information about 
screening or monitoring services effectively, thereby increasing awareness of 
the services provided (Freitas et al., 2012). Despite increasing awareness of 
the services, patients may still lack understanding of the importance of 
adherence, which is one of the factors that contribute to non-adherent 
behaviour (Moore, 2012).  
d. Support networks. These can be in the form of family or health professionals 
(Maldaner et al., 2008). Freitas et al. (2012) affirmed that the interaction 
between patient and health care providers plays a key role in adherence. Nteta 
et al. (2010) reported that unfriendly and uncaring behaviours of health care 
workers affected the use of health care services in their study. In support of 
this finding, Govender and Mash (2009) suggested that relationships between 
patients and TB staff, in a South African setting, would be enhanced by 
improving communication skills of TB nurses. A case study was conducted by 
van der Walt (2004) at a tuberculosis control programme in the Western Cape 
Province. The findings showed that participants’ responses on the whole 
indicated that the group of white nurses were less angry and judgemental 
about their TB patients than were their coloured1 counterparts. It appeared that 
when patients were seen as different by the nurses in terms of class, race, 
income, educational background, closer contact was less threatening. She 
further suggested that because the study was conducted in post-apartheid 
South Africa, the white nurses’ tolerance may have been strengthened by guilt 
(van der Walt, 2004). Although not focused exclusively on TB treatment or 
primary health care facilities, a report by Vivian, Naidu, Keikelame and Irlam 
(2011) highlighted continued concern regarding the abuse of patients’ human 
rights in South African health care facilities. Thus, it could be argued that the 
                                                          
1 In South Africa the term coloured (also written Coloured) is used to refer to people of mixed-race parentage rather 
than, as elsewhere, to refer to African peoples and their descendants (i.e. as a synonym for black). Under apartheid it 
was imposed as an official racial designation. However, in modern use in South Africa the term is not generally 
considered offensive or derogatory. 
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quality of interactions with the health professionals might impact the use of 
ototoxicity monitoring services.   
Social/Economic Related Factors 
e. Getting time off work. Difficulty getting time off from work to attend a 
clinic was noted by Nteta et al. (2010) as a barrier. Burdensome work 
schedules are associated with poor adherence to medication regimen in 
patients with breast cancer receiving oral therapies (Moore, 2012). Despite 
cancer and tuberculosis being different diseases, both require adherence for 
the success of the treatment therapy respectively.  
f. Family support networks. When managing a patient, the International 
Classification of Functioning, Disability and Health (ICF) framework 
recommends including the individual’s family in the management (WHO, 
2001). Evidence has been found that significant others have positive impact 
on the patient’s progress in rehabilitative context (WHO, 2001). Maldaner and 
colleagues’ (2008) study of patients undergoing haemodialysis treatment 
reported support networks as one of the factors that influence the utilisation of 
services. If the family or spouse is supportive and constantly reminds the 
patient, he/she is most likely going to go through the treatment and complete it 
(Maldaner et al., 2008). Nteta et al. (2010) confirmed the impact of family 
influence on the patient in the utilisation of primary health care services.  
            Ushie and Jegede (2012) reported that co-infection with TB and HIV is a source 
of tension in the family.  Their study set in Nigeria, examined circumstances under which 
family support promotes or hinders adherence to treatment for HIV and TB/MDR-TB co-
infected patients. Findings showed that overall, family support does promote adherence. 
Family support may however, have negative effects on adherence when the patient 
perceives that the support is being given with ulterior motives. For example, gossiping 
about the patient and when the patient has the primary source of income (for example, the 
recipient of a social grant) he/she may feel that his/her role is being undermined. The 
same authors argued that the stigma about HIV made some participants less likely to 
come forward for treatment even if they had only TB because of the association between 
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TB and HIV (Ushie & Jegede, 2012). These findings may be applicable in the South 
African context where co-infection with TB and HIV is also common (Harris, Bardien, et 
al., 2012).  
Patient Related Factors  
1. Self-efficacy  
Self-efficacy has been identified as an important determinant of rehabilitation 
adherence (Levy et al., 2008). Moore (2012) wrote that patients who have a high level 
of control over their health are likely to adhere to their prescribed regimen. Levels of 
self-efficacy differ (Morris & Schulz, 1993 as cited in Moore, 2012) among 
individuals with a similar socio-economic status and education level, but adherence is 
superior in those with high self-efficacy skills (Moore, 2012).   
2. Attitude and beliefs 
 Levy et al. (2008) reported that attitude of patients and their perceived severity of 
sport injury were found to predict the intention of making use of rehabilitation services. 
Attitude and beliefs greatly shape an individual’s behaviour, in terms of whether he/she 
will observe the outlined recommendations or not (Levy et al., 2008). In line with this 
variable, Shelton, Jandorf, Ellison, Villagra and DuHamel (2011) introduced the notion 
of fatalism. Fatalism is defined as ‘a belief that a person’s behaviour does not exert 
control over events that happen’ (Shelton et al., 2011, p. 926). This research questioned, 
in the context of ototoxicity monitoring, if resignation with regards to the development of 
hearing loss promoted the non-use of ototoxicity monitoring services. Maldaner et al. 
(2008) conversely argued that accepting the disease as a factor that positively influences 
adherence. Hence, if patients are in denial regarding the diagnosis of TB, resignation 
could become a barrier to the utilisation of the services. Acceptance can thus be a 
facilitator for some individuals to have their hearing continuously monitored even if a 
hearing loss has already been acquired because they accept having TB and the ototoxic 
consequences that comes with it.  
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Belief in the supernatural and traditional healers remains a feature in the South 
African cultural medical paradigm due to the difference in worldview between modern 
and traditional cultures; which tend to shape people’s perception of health matters (de 
Andrade & Ross, 2005). A strong belief that disease can be brought on by spiritual 
pollution is common within the traditional philosophy (de Andrade & Ross, 2005). A 
traditional healer is defined as ‘someone who is recognized by the community in which 
he lives as competent to provide health care services’ (Pretorius, de Klerk & van 
Rensburg, 1993, p.5). It is estimated that eight out of ten black South Africans consult 
traditional healers in conjunction with modern Western health professionals (de Andrade 
& Ross, 2005). de Andrade and Ross (2005) stated that traditional healers may be more 
physically and geographically accessible to the people and approximately 2.9% consult 
traditional healers for ear-related problems. They further noted that traditional medicine 
tries to explain why a particular person has been affected at that point in time, thereby 
introducing the notion of a cosmological aspect to the disease. Therefore, despite the 
medical professional having explained the cause of the disorder e.g. hearing loss due to 
ototoxic effects, there is a chance that patients could still ascribe the hearing loss to 
supernatural causes. In de Andrade and Ross’ study they found that ten of the fifteen 
traditional healers interviewed credited the cause of hearing loss to ancestors, above other 
aetiologies such as noise exposure or congenital factors and only four traditional healers 
attributed it to bewitchment. Due to the regard of communities for traditional healers and 
the ease of access, it is suggested that collaboration of health care professionals and 
traditional healers could be beneficial (de Andrade & Ross, 2005).  
3.  Age 
          Age is a factor reported as affecting adherence or service utilisation, but 
inconsistently (WHO, 2014). Scott (2009) reported on a study conducted on patients who 
are prescribed medication to treat high cholesterol. The findings showed that more than 
50% of patients under the age of 45 were not optimally adherent to their therapy with 
58% of adults between the ages of 18 and 34 not taking their cholesterol-lowering 
medications as prescribed (Scott, 2009). Achmat and Roberts (2006) however indicated 
that patients can feel disempowered especially older adults from disadvantaged 
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backgrounds, who may have previously experienced a more patriarchal health care 
system thereby affecting their adherence and utilisation of the health care facilities.  
4. Health literacy  
The extent to which a patient can read, understand and carry out the health 
recommendations plays a role in how well a patient will follow a prescribed regimen 
(Ross, 2007). There is a low education level among adults in the Khayelitsha community 
(City of Cape Town, 2011) therefore it is possible that patients may struggle with 
understanding and following the recommendations given to them thus hindering 
adherence. A study conducted by Schmidt von Wühlisch and Pascoe (2010), based in 
Cape Town, found that patients in the health care sector frequently struggle to understand 
and remember details of clinical information and the reasons underlying their treatment. 
As a result they often do not adhere to clinical instructions and recommendations causing 
reduced effectiveness and efficiency of health care interventions (Kessels, 2003 as cited 
in Schmidt von Wühlisch & Pascoe, 2010).          
Condition-Related Factors 
Hearing loss as a condition-related factor was explored since adherence can be 
affected by the absence or severity of a hearing loss (Garstecki & Erler, 1998). Greater 
hearing loss was seen to play a critical role in influencing better adherence to health care 
services in a study conducted by Garstecki and Erler (1998). Conversely, Fallabi-Stubi et 
al. (1998) reported that compliance with treatment in a TB programme decreased over 
time because patients were asymptomatic. It is therefore often difficult to convince 
patients of the importance of taking their medication for several months (Fallabi-Stubi et 
al., 1998). Extending this notion, it is possible that due to the effects of hearing loss not 
being immediately apparent, patients may not appreciate the perceptible benefit of 
monitoring their hearing and are less likely to adhere or persist with the programme 
(Moore, 2012).  
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Therapy-Related Factors 
Factors related to therapy which may impact adherence include the duration of 
treatment, previous treatment failures, frequent changes in treatment, the immediacy of 
beneficial effects, side-effects, and the availability of medical support to deal with them.   
(WHO, 2014). MDR-TB treatment is lengthy and complex often with unpleasant side 
effects which affect adherence to treatment (Duggal & Sarkar, 2007; TB Alliance, 2015). 
Patients might be too ill to walk to where the services are for their treatment or 
ototoxicity monitoring and in some cases they are hospitalised thereby affecting 
adherence (MSF, 2011; TB Alliance, 2015).   
Problem Statement 
  The management of MDR-TB in general presents some challenges. These 
challenges that occur as MDR-TB treatment tends to be lengthy and difficult (Duggal & 
Sarkar, 2007; TB Alliance, 2015). Prior to the introduction of the decentralised model of 
management of DR-TB, patients treated with aminoglycosides were often audiologically 
monitored at TB hospital as inpatients (Western Cape Government, 2011). The transition 
for monitoring inpatients to outpatients therefore made the ototoxicity monitoring 
services more accessible at a community level in one area (e.g. Khayelitsha sub-district), 
while the central TB hospital offered an outpatient service as well. However, uptake of 
such services was not known. This study therefore aimed to explore the barriers to and 
facilitators of the utilisation of ototoxicity monitoring services when such services are 
provided under an outpatient MDR-TB model of care. 
 
     Study Rationale    
This study was set to identify the factors that would facilitate individuals to make 
use of ototoxicity monitoring services. The shift in policy towards decentralisation would 
hopefully signal the political will to prioritise treatment of TB in the community. In 
addition it would be hoped that this will include monitoring for, and response to, the 
adverse effects of TB, including hearing loss. Considerable resources have been invested 
in order to establish these services therefore information regarding their uptake is 
important. Identifying the facilitators and barriers would help inform service delivery, 
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thereby improving the effectiveness in providing ototoxicity monitoring services to the 
public.  While cost-effectiveness per se will not be evaluated, it could be argued that to 
provide services, which are not used to maximum impact, is not efficient spending of 
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Chapter Three: Methodology 
Introduction: This chapter will present a description of the research methodology 
used in this study. This study was conducted in two phases, and therefore the study 
design, data collection methods and procedures, reliability and validity issues will be 
described separately for each of the two phases. The chapter will close with a description 
of ethical considerations applicable to both phases.  
Aims & Objectives 
The study had two aims. First, to determine the pattern of the utilisation of 
ototoxicity monitoring services when provided on an outpatient basis. Second, to explore 
factors that act as facilitators of and barriers to the use of ototoxicity monitoring services 
for outpatients receiving treatment for MDR-TB. The study was conducted in two phases 
to address each of the aims of the study. 
Phase 1  
Aim  
To determine the pattern of utilisation of ototoxicity monitoring services for patients with 
MDR-TB who accessed treatment on an outpatient basis.   
Objectives 
1. To describe the pattern of utilisation of ototoxicity monitoring services for 
outpatients with MDR-TB using descriptive statistics at a central TB facility.  
2. To describe the factors associated with attendance of available ototoxicity 
monitoring for outpatients with MDR-TB. The following variables were used: 
age, gender, treatment regimen, place of referral, initial hearing status, 









To explore factors that act as facilitators of and barriers to the use of ototoxicity 
monitoring services for patients who are receiving their treatment for MDR-TB as 
outpatients. 
Objectives 
1. To develop and pilot a questionnaire based on literature, which explores patients’ 
opinions regarding the barriers and facilitators of use of audiological services.  
2. To administer the finalised questionnaire to patients with MDR-TB who were 
currently accessing treatment on an outpatient basis to investigate the factors that 
impact the utilisation of the ototoxicity monitoring services.  
 




Figure 1: Flow chart of methodology  
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Study Context  
The study was conducted in Cape Town Metropolitan area at two facilities which 
provide MDR-TB care on an outpatient basis. Facility 1 was located in a more central 
location in the Metropole, whereas facility 2 was located in one of the biggest townships 
in the Cape Town Metropole. 
Description of the Two Facilities 
Facility 1: A centrally located TB hospital. The facility has 350 in-patient beds 
and is meant for long-term admission of MDR-TB patients. The facility also has a large 
outpatient department which receives referrals from as far as the Cape Winelands 
(approximately 167km away) and Eden area of Western Cape which is approximately 
431km away.  
At this facility, ototoxicity monitoring for MDR-TB patients is done bi-weekly or 
monthly according to the audiologist’s decision, taking into account each individual’s 
hearing status. The decision is guided by evidence based guidelines. The patient has to 
attend the first hearing test appointment and from then, would be given a subsequent 
follow-up appointment. The same routine is observed for all the follow-up visits. The 
resident audiologist conducts the pure tone air conduction test in an audiometric booth. 
The facility is also responsible for ototoxicity monitoring of patients referred from 
neighbouring primary health care facilities.   
Facility 2: A primary health care facility in a peri-urban township on the outskirts 
of Cape Town; characterised by a mixture of formal and informal housing and a lack of 
access to basic services (City of Cape Town, 2011). Its population, according to the 2011 
census, was 392 749 with mostly Xhosa-speaking people (City of Cape Town, 2011). A 
study previously carried out in this community showed that there is an extremely high 
burden of MDR-TB; estimated at 51/100,000/year (Cox et al., 2010). Cox et al. (2010) 
stated that in 2008, the two clinics in this community were responsible for diagnosing and 
treating approximately 50% of TB cases in Khayelitsha. Ototoxicity monitoring was set 
up at a central location (community health clinic) and all MDR-TB patients from the 
neighbouring 13 primary health care clinics were referred there. The monitoring is 
conducted by a trained lay-person on a monthly basis while the patient usually attended 
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the clinic daily for DOTS (MSF, 2011). The overall management of the programme is 
conducted by an Audiologist.  
Phase One Retrospective Record Review 
 Research Design  
This study was a descriptive, quantitative research study in that it was concerned 
with identifying patterns or trends in a situation, without regard to causal or other 
hypothesis (Grimes & Schulz, 2002). A descriptive, quantitative study uses numerical 
analysis and places emphasis on objective measurements of data collected through polls, 
surveys or questionnaires and establishes only associations between variables (Hopkins, 
2000). A retrospective record review of patient medical records was conducted which 
investigates the past and involves viewing data that have already been collected, using 
pre-set criteria and standards (Jansen et al., 2005; Zegers et al., 2007). The advantages of 
using a retrospective record review are that it is easy to perform and it is also economical. 
The disadvantages are that relevant information might be missing from the patients’ 
records or that patients’ records do not detail the associated reason behind choices made, 
such as why the patient utilised or did not utilise the ototoxicity monitoring services 
(Jansen et al., 2005).    
 
Participants  
Medical records of adult patients who were accessing treatment for MDR-TB, as 
outpatients at a central-TB hospital based in Cape Town, South Africa were reviewed.  
Inclusion criteria  
 Patients treated for MDR TB with a regimen that includes an aminoglycoside.  
 Patients who accessed ototoxicity monitoring services as outpatients at a central 
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Exclusion criteria 
 Inpatients were excluded because it is more feasible to monitor inpatients and 
ototoxicity service utilisation on an outpatient basis was being explored.  
 Newly diagnosed TB patients who only had one hearing test appointment 
scheduled at the time of the review were excluded as a trend for attendance could 
not be assessed with just one visit. At least two hearing test appointments were 
required to have been scheduled after commencing MDR-TB treatment in order 
for a pattern to be drawn. 
 Participants with missing information pertinent to the study such as treatment 
regimen were also excluded from the study. 
Sample Size  
A total of 860 medical folders were reviewed and out of those, 59 records did not 
meet the inclusion criteria and were ineligible due to missing information pertinent to the 
study, leaving 801 folders to be used in the study. For a descriptive quantitative study, 
Fox, Hunn and Mathers (2009) suggested using the following formula below in order to 
obtain the required sample size of 385 which was considered adequate for this study.  
 N =           
   
 
where confidence level is 95%, p=50% and the standard error being 2.55 
     =                 
     
    =      
    
    = 384. 6 = 385 
Based on the calculations, the sample size of 801 was therefore adequate for the purpose 
of this study.  
 
Data Collection Tool 
A data collection sheet was developed for the purposes of this study. Key areas of 
interest were derived from recommendations from the literature and included in the data 
collection sheet, (see Appendix A). The same information that was on the data collection 
sheet was then placed onto an M.S. Excel spread sheet for transferring the data onto a 
password protected computer.  




 The primary researcher conducted the record reviews of the participants. No other 
research staff members were involved. 
Data Collection and Procedure 
Ethical clearance was sought and obtained from the Faculty of Health Sciences 
Human Research Ethics Committee at the University of Cape Town, (HREC REF: 
604/2012, see Appendix B and C). Permission to conduct the study was obtained from 
the Provincial Government of the Western Cape (PGWC) before any part of the study 
was conducted; in order to access patient files (RP 168/2012 see Appendix D). Once 
permission was granted, the data of all the MDR-TB outpatient files in the audiology 
department were reviewed on-site. Patients who did not make it into the audiology 
department system via the first hearing test were therefore lost in the referral system 
whether due to being ill, died or being discharged (Nkosi et al., 2013). The files were 
drawn, the data collection sheet completed and transferred to Excel. Quality assurance 
procedures were followed then the data was coded and analysed. 
Data Analysis 
Analysis of data was done to investigate how the following factors influence 
patterns of utilisation of services: age, sex, treatment regimen, place of referral, waiting 
period from the time of inclusion in the MDR-TB programme to the first audiologic 
assessment, initial hearing status, development of hearing loss and the presence 
and/development of disabling hearing loss.  Only the first six appointment visits were 
reviewed despite ototoxicity monitoring being conducted either bi-weekly or monthly. 
Six visits is the minimum number of audiologic visits expected because ototoxic 
aminoglycosides are given daily for the first six to eight months (Brust et al., 2014; TB 
Alliance, 2015). 
Both descriptive and inferential statistical methods of data analysis were used. 
Descriptive statistics such as the mode and median were used to provide a summary of 
the data collected. In addition the variables that influenced attendance were assessed with 
the relative risk estimation by log-binomial regression using the generalised linear 
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modelling. When the outcome event is common as in case of this study, (incidence of 
10% or more) (Lindquist, 2014), it is often more desirable to estimate a relative risk/risk 
ratio (RR) instead of using odds ratio (OR) since there is an increasing differential 
between the RR and OR with increasing incidence rates (Greenland, 2004; McNutt, Wu, 
Xue & Hafner, 2003; Zou, 2004). The log-binomial model has been proposed as a useful 
approach to compute an adjusted relative risk as it produces an unbiased estimate of the 
adjusted relative risk (McNutt et al., 2003). From the results obtained, variables that were 
statistically significant had a p-value <0.05 and an RR value < 1 for any specific variable 
indicated less likelihood of attendance of a hearing test appointment when compared to 
the reference variable (Harrell, Califf, Pryor, Lee & Rosati, 1982). An RR value greater 
than 1.0 indicated more likelihood of attendance when compared to the reference variable 
(Harrell et al., 1982). 
Classification of Hearing Status  
The hearing status at the initial hearing test appointment was used to categorise 
hearing loss according to Margolis and Saly (2007) where normal hearing was ≤ 25dB 
HL and hearing loss was ≥26 dB HL. WHO uses 0.5 kHz, 1 kHz, 2 kHz and 4 kHz pure 
tone averages to define disabling hearing loss (WHO, 2010). Standard pure tone averages 
of 0.5 kHz, 1 kHz and 2 kHz were however used because Valete-Rosalino and Rozenfeld 
(2005) stated that these frequencies are considered important in the identification of the 
disability related with hearing. Development of ototoxic hearing loss was described 
according to the ASHA (1994) criteria where a significant hearing threshold change is 
defined as a 10 dB HL change in two consecutive frequencies, a change of greater than 
20dB HL in any one frequency, or an absence of response at 3 consecutive test 
frequencies in which responses were previously present and this is across the 0.25 kHz to 
8 kHz frequency range. Development of hearing loss was assessed only for patients who 
attended more than once in order to ascertain any shift in their hearing thresholds. A 
disabling hearing loss was described using the criteria from WHO which refers to hearing 
loss greater than 40dB HL in the better hearing ear in adults and a hearing loss greater 
than 30dB HL in the better hearing ear in children (WHO, 2014). The use of the best ear 
is justified by the fact that the worst ear tends to be compensated by the function of the 
better ear (Valete-Rosalino & Rozenfeld, 2005).  
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Phase Two Questionnaire development and Administration 
Research Design 
An exploratory quantitative approach was used. Salkind (2012) stated that an 
exploratory study is conducted in order to provide insight and understanding through the 
use of a survey questionnaire. Mitchell and Jolley (2012) stated the advantages of using a 
survey as that a large amount of information can be collected from a large number of 
people in a short period of time and in a relatively cost effective way. In addition, the 
results of the questionnaires can usually be quickly and easily quantified and can also be 
analysed more objectively than other forms of research. However, if the participant’s 
self-report is inaccurate, the survey will have poor construct validity (Mitchell & Jolley, 
2012). In addition, the survey is argued to be inadequate for understanding some forms of 
information, for example, changes of emotions, behaviour, or feelings (Mitchell & Jolley, 
2012). The latter was addressed in the administration of the final questionnaire where 
participants were given an opportunity to give the reasons qualitatively, behind choices 
made regarding utilisation of the services. 
 
Participants 
Participants were adults who were receiving treatment for MDR-TB as outpatients 
at a central TB hospital and at a primary care clinic between April 2013 and September 
2013. 
Inclusion criterion.  The inclusion criterion was MDR-TB individuals exposed to 
aminoglycoside treatment who were currently receiving treatment and were 18 years of 
age and older at the time of the study.  
Exclusion criteria.  The exclusion criterion were participants who took part in 
the pilot study (described on page 43), those who had completed their TB treatment and, 
inpatients at facility 1. By default those who were not using the facility even though this 
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Sampling Frame  
 According to Gross, Mallory, Heiat, and Krumholz (2002), a sampling frame is 
the set of source materials from which the sample is selected. In this case it was adult 
MDR-TB outpatients, receiving aminoglycoside treatment from Facility 1 or 2. In a 
sampling frame, patients undergo eligibility screening to determine the eligibility fraction 
(Gross et al., 2002). The eligibility fraction in this study included those on 
aminoglycoside TB treatment and were 18 years of age and older. Those eligible for 
participation were then asked for informed consent. There were 90 people in the sampling 
frame, 10 were screened, 6 did not give consent to participate and 74 were included in the 
study.   
Recruitment Strategy 
At Facility 1, the recruitment strategy was to approach potential participants from 
the Audiology Department after attending their hearing test appointment. At Facility 2, 
participants were recruited at the clinic when they came for their DOTS visits or attended 
the MDR-TB support group. The purpose of the study was explained to them (see 
Appendix E) and informed consent was then sought from them to participate in the study 
(see Appendix F). Participants were approached by the researcher at Facility 1 and the 
help of the support group facilitator was used at Facility 2.  
Sampling Method 
A convenience, non-random sampling method was used. Convenience sampling 
makes use of readily available people who volunteer to participate in the study (Burns & 
Grove, 2001; Terre Blanche et al., 2006). This sampling method should however, be used 
with caution as the participants may be atypical and introduce bias to the study (Polit & 
Beck, 2008). The major obstacle with the sampling strategy was that the non-attendees 
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Sample Size 
For a quantitative study, a large sample is recommended, the larger the sample the 
more representative it is (Polit & Beck, 2008). A sample size calculation suggested 
having 348 participants (Raosoft, 2004). The calculation was based on the normal 
distribution and the following formula was used:  
Sample Size =                   
Confidence Interval (m) =   
  
            
           
 
Where, 
Z = Confidence Level (E.g. 1.96 for 95% Confidence Level),  
p = Worst case percent (Default value: 0.5), 
m = Margin of error (or) Confidence Interval. 
A total of roughly 860 MDR-TB registered outpatients were seen at the 
Audiology Department at Facility 1 from January 2012 to the period of the study and 
about 317 MDR-TB patients were seen at Facility 2 (K. Jacobs, personal communication, 
December 9, 2013). The recommended sample size was based on a 95% confidence level 
and +/-5% margin of error (Polit & Beck, 2008). According to Burns and Grove (2001) 
there is however, no hard and fast rule about the sample size for a quantitative study and 
a sample of at least 30 participants should be used. A total sample size of 74 participants 
was used and given the exploratory nature of this study, this sample size was therefore 
considered adequate. 
Data Collection Tool 
The primary data collection tool for phase two was a questionnaire (see Appendix 
H for the final questionnaire) developed specifically for the purpose of this research. The 
questionnaire was carefully piloted and necessary changes made before it was 
administered to the main sample.  
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The questionnaire used a structured four-point Likert scale response format to 
avoid the neutral response. A Likert scale is appropriate as it allows the answers to be 
weighted, allowing for more natural responses (Ghurman, 2010). Traditionally, Likert 
format is a five-point scale, in which the options are ‘strongly agree’, ‘agree’, ‘neutral’, 
‘disagree’ and ‘strongly disagree’ (Kaplan & Saccuzzo, 2009). Using even numbers on a 
Likert scale forces the respondent to choose an option hence giving better responses 
(Ghurman, 2010; Polit & Beck, 2008). 
Questionnaire Development 
Step 1. The first step was to develop the draft questionnaire using literature (see 
Appendix G). According to Trochim (2006), the actual process of developing a 
questionnaire comprises the following steps: 
1. Determining the question content, scope and purpose. 
2. Choosing the response format that will be used for collecting information 
from the respondents. 
3. Wording the question appropriately in order to get at the issue of interest. 
 
Some of the qualities that make a good question are noted below (Bright, 2009) and were 
adopted during the development of the questionnaire: 
1. Asks for an answer on only one dimension. 
2. Can accommodate all possible answers. 
3. Have mutually exclusive options. 
4. Produces variability of responses. 
5. Follows comfortably from previous questions. 
6. Does not presuppose a certain state of affairs (the phrase ‘do you think’ was 
continuously used in the questionnaire to address this point). 
7. Does not imply a desired answer. 
8. Does not use emotionally loaded or vaguely defined words. 
9. Does not use unfamiliar words or abbreviations. 
10. Is not dependent on responses to previous questions for example, in question 
2, even if the participant has never missed an appointment before, they were 
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asked if they would miss it because of different reasons given (see final 
questionnaire Appendix H).  
Step 2. The next step was using a modified Delphi technique to gain consensus about 
the content and wording of the questions formulated which is suggested by Mayland, 
Williams and Ellershaw (2011) when developing a questionnaire. Therefore a Delphi 
panel of five members was assembled to review the questions proposed for the 
questionnaire. A research information letter was given to them and consent was obtained 
(see Appendix I). The qualifications of the panellists were as follows: two audiologists 
knowledgeable in the field of ototoxicity, a doctor, nurse and an audiometrist. The last 
three Delphi panellists were staff members based at a clinic involved with patients on 
MDR-TB treatment. This was a purposive sample and the sample size for the panel was 
considered adequate for a Delphi panel consensus for this study (Conroy, Elliot & 
Burrell, 2013). 
Two rounds of the Delphi were conducted based on the two-staged modified Delphi 
procedure (Hsu & Sandford, 2007; Reiter et al., 2007). In the first round, the draft 
questionnaire was either emailed or the panellists were asked for the feedback in person.  
The panellists were required to give comment regarding the changes that could be made 
to the structure and wording of the questionnaire. Space for feedback was left after each 
question. At the end of the draft questionnaire, the panellists were asked whether they had 
additional suggestions, for example, adding questions that had not been included. Results 
from the first iteration of the panel led to the removal of the questions in bold (see 
Appendix G) because there were not relevant to the particular setting or were repetition. 
The remaining questions were accepted immediately after one review as consensus was 
80% (Olthof et al., 2013). These changes were implemented and a second Delphi round 
was carried out. A second draft of the questionnaire was returned to the panel and 
included qualitative suggestions from the first round. The second round focused on 
obtaining a consensus regarding the edited draft questionnaire. Consensus of 50% was 
reached and was adequate (Conroy et al., 2013) as no new information was obtained and 
no further changes or suggestions were made by the panellists. The 50% agreement was 
decided based on the stability of the panellists’ responses from the previous round and 
also because only agreement, rather than new knowledge, was sought in this round (Hsu 
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& Sandford, 2007; Mash, Couper & Hugo, 2006). This second draft then became the final 
draft questionnaire (Kalaian & Kasim, 2012) (see Appendix H).  
Step 3. After a consensus regarding the questions was reached, the next step was 
to analyse the language level of the questionnaire prior to administration to the 
participants. A Flesch-Kincaid analysis of the English version of the questionnaire was 
completed in order to analyse the language level of the questionnaire (see Appendix J). 
Readability level of Flesch-Kincaid grade level 3 was acceptable (Paasche-Orlow, Taylor 
& Brancati, 2003). Text written at a 4th-grade level would promote the autonomy of most 
candidates for participation in medical research (Paasche-Orlow et al., 2003). Several 
healthcare agencies have recommended that the readability of patient education materials 
should not be higher than sixth- to eighth-grade level (Badarudeen & Sabharwal, 2010) 
but in the South African context, considering the community in which the study was 
performed, grade 3 level was used.  
Step 4. Once the assessment of the language level was completed, the 
questionnaire was translated into isiXhosa, because the population in which the study was 
conducted consisted predominately of isiXhosa speaking individuals. The National 
Language Policy Framework in South Africa states that individuals have the right to 
access information in the language they prefer (Constable, Mabena & Minishi-Mjanja, 
2007). When translating the questionnaire, the forward translation technique was used in 
the translation of the original English version into isiXhosa (Wild et al., 2005). A mother 
tongue isiXhosa speaker who was also proficient in English and a graduate at an English 
medium university did the translation. After translating the questionnaire cognitive 
debriefing is recommended (Ploughman, Austin, Stefanelli & Godwin, 2010). It is 
recommended because it is part of the translation process, where people from the target 
population are invited to review a translated questionnaire (see Appendix K) in order to 
determine if the content and items are understood in the same way the researcher 
intended (Ploughman et al., 2010). However, this was not achieved because of the low 
literacy levels of the population in which study was conducted. The translated 
questionnaire was then piloted in order to assess the feasibility of administering the 
questionnaire and a backward translation was performed by a different individual in order 
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to check for vocabulary equivalence (Cuellar & Paniagua, 2000). Back translation is 
particularly valuable to researchers who do not have the proficiency in the translated 
language as it can assure some control over the eventual product when the back 
translation occurs to the source language (Cuellar & Paniagua, 2000).  The results of the 
forward-backward translation were equivalent to the original English version. 
Step 5. Piloting the questionnaire: After developing the questionnaire, a pilot 
study of the isiXhosa questionnaire was conducted and is discussed more in detail below. 
Permission to access the facilities had been obtained from PGWC (see Appendix D) and 
from the City of Cape Town (see Appendix L). 
Pilot Study 
Aim (Pilot Study): To assess the feasibility of the isiXhosa questionnaire in terms of its 
administration. 
Objectives: 
a. To identify any specific unclear items 
b. To establish the average time it will take to complete the questionnaire  
c. To assess if the participants can self-administer the questionnaire 
Participants for the Pilot Study 
Inclusion criterion. The inclusion criterion was adult, MDR-TB participants 
exposed to aminoglycosides at Facility 2 and who reported they could read and write in 
isiXhosa.  
Exclusion criterion. Exclusion criterion was MDR-TB patients who were 
illiterate and those who had completed their TB treatment, since they no longer utilised 
the ototoxicity monitoring services. The current facilitators of and barriers to the use of 
ototoxicity monitoring services were therefore being explored. 
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Participants had to be able to self-administer the questionnaire without assistance 
in order to obtain the individual’s own view without influence (Georgoudisa, Oldhama & 
Watson, 2001). This meant that the participants had to be functionally literate in isiXhosa 
in order to self-administer the questionnaire. Functional literacy is defined as the ability 
to understand and use printed information in daily activities in a variety of settings 
(Chigona, Van-Belle, Moore, Paddock & Pitout, 2005). In the community where the 
study was carried out, 75.4% of the adults’ highest level of education is less than a matric 
certificate (City of Cape Town, 2005).  Targeting a grade 3 literacy level was to ensure 
that the criterion does not automatically exclude the majority of the population, 
considering that there is a low literacy level among adults in this community (City of 
Cape Town, 2005).  
Pilot Sample Size 
Thabane et al. (2010) stated that a sample size in a pilot study may not be required 
but it must be representative of the population and have the same inclusion and exclusion 
criteria as the population in which the final questionnaire will be administered. Because 
the sample size depends on the purpose of the pilot study, a sample size of seven 
participants was used in this study (Johanson & Brooks, 2009).   
Pilot Study Procedure 
The researcher, with the help of the counsellor in charge of facilitating the support 
groups, approached the potential participant, explained the purpose of the study and 
obtained informed consent. Based on the counsellor’s experience as well as the 
experience of other staff members at the clinic working with the TB patients, it was 
advised to have the questionnaire only verbally administered in isiXhosa in order to get 
reliable responses therefore the third objective was not explored. The participant was led 
into a private space where the questionnaire was researcher-administered.  An open-
ended question was included to ensure that if in any way the questions presented were 
biased, the participants still got an opportunity to inform the researcher of their reasons 
for utilising or not utilising the audiological services. On completion, the researcher 
thanked the participant for their help in the research and gave them an airtime voucher as 
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a token of appreciation. The time taken to administer the questionnaire was noted for 
each participant.  
 
Results from the Pilot Study 
From the findings from the pilot study, no adjustments were made to the 
questionnaire. Only one procedural change was made; having a first language isiXhosa 
speaker verbally administering the questionnaire instead of it being self-administered by 
participants. This was done because it was advised that the participants were unable to 
self-administer the questionnaire reliably so in order to ensure uniformity, all the 
interviews were conducted verbally. The average time the researcher took to administer 
the questionnaire was 10 minutes.  
 
Administer Final Questionnaire at Facility 1 and 2 
The procedure for administering the final questionnaire at facility 1 and 2 was that 
the researcher and assistant first approached the participant, explained the purpose of the 
study and obtained informed consent. The participant was then led into a private room or 
space outside where the questionnaire was administered verbally by the assistant, a first 
language isiXhosa speaker for isiXhosa speaking participants. On completion, the 
researcher thanked the participants for their help in the research. Airtime vouchers were 
given as a token of appreciation for participants at Facility 2.  
Data Management 
The raw data (completed questionnaires) were stored in a locked cabinet. Once 
the data had been transferred to an Excel spread sheet, results were stored on a password 
protected computer. No identifying information about the participant was recorded in the 
questionnaire and each participant was coded in terms of letters and numbers.  Quality 
assurance to check the accuracy of the data collection was conducted and will be 








A non-parametric, Mann-Whitney U test was used to compare differences 
between two independent groups i.e. females and males. It allows one to inferences from 
the data such as stating whether the two populations differ and determining if there are 
differences in medians between groups (Tredoux & Durrheim, 2002). Fisher’s exact test 
was also used because it is a similar analysis and is recommended for small size samples 
(Polit & Beck, 2008). Fisher’s exact test is used to analyse contingency tables, which 
display the interaction of two or more variables, and it calculates exact statistical 
significance, rather than using an approximation (Foster, 2014). Gender disparities have 
been known to exist in the overall use of health care services but the same has not been 
investigated for preventative care utilisation (Vaidya, Partha, Pharm & Kamakar, 2012). 
A frequency count of the factors noted to influence the utilisation of ototoxicity 
monitoring services was conducted. Frequency count is defined as the number of times a 
given phenomenon appears (Polit & Beck, 2008).    
 
Reliability and Validity 
Reliability   
Reliability refers to the consistency or stability of a test, the extent to which an 
instrument yields the same results on repeated trials (Terre Blanche et al., 2006). For the 
retrospective record review in phase one, in order to reduce error during data collection, 
quality control procedures were instituted. These procedures were on how and which data 
to collect, how to record potentially ambiguous information and how to distinguish 
between missing and inappropriate data (Tejani & Wasdell, 2010).  
A potential threat to reliability in this study for phase one was that data may not 
be entered correctly on the Excel spread sheet. In order to address this threat, test-retest 
reliability was used. For test-retest reliability, 5% of the patients’ data collected by the 
same individual was re-entered and the entries were compared using the IF() and the 
COUNTIFS() formula to compare the data sets (Harkins, 2012; Singh et al., 2011; Tejani 
& Wasdell, 2010). The formula ‘=IF (’ was typed into any Excel cell, which prompts one 
to highlight the data set to be compared and specify using ‘zero or incorrect’ to identify a 
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mismatch in the data. After selecting the data, the formula was concluded by closing the 
brackets and pressing enter. Any errors in the data then appeared labelled ‘zero or 
incorrect.’ A similar procedure was conducted with the COUNTIFS formula to get the 
percentage of errors. A percentage discrepancy was used in order to accept or reject the 
data (Hogg et al., 2010). For data verification, 95% accuracy is usually used in health 
care settings (Tejani & Wasdell, 2010). No value was entered on the Excel spread sheet 
for any missing data and calculations were made based on the available data only. A 
percentage accuracy of 98% was obtained for the data.  
 For phase two, one way of achieving reliability was through pilot testing the 
questionnaire. Pilot testing an instrument allows for the identification of sources of error 
which would affect its reliability (Kimberlin & Winterstein, 2008). Refinement of the 
instrument then focuses on minimizing measurement error (Kimberlin & Winterstein, 
2008). In an attempt to maintain reliability, the researcher provided training to the 
research assistant. In addition, the researcher sat in throughout the administration process 
and corrected the assistant on how to get the responses where necessary. The assistant 
was told not to paraphrase the questions but simply read them out and fill in the 
questionnaire. The participants were also advised that there was no wrong answer in 
order to minimise the Hawthorne effect and social desirability issues.   
Validity 
 Construct validity means a tool is measuring what it was set out to measure 
without neglecting important components (Burns & Grove, 2001; Twycross & Shields, 
2004). In order to ensure that the data collection sheet was valid, evidence from the 
literature was used to develop it for phase one (Burns & Grove, 2001; Twycross & 
Shields, 2004). 
For phase two, content validity is one of the measures that were used to assess the 
validity of a tool. A rigorous way of doing so is by asking recognised experts in the area 
to give their opinion on the validity of the tool (Kimberlin & Winterstein, 2008; 
Twycross & Shields, 2004). This was achieved by conducting a literature review to 
develop the tool and by using the Delphi technique and pilot study to ensure that no 
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important components were neglected. These last two procedures ensured that the 
questions asked were appropriate and acceptable culturally to this population.  
The challenges that were faced with the Delphi panel were the lack of 
understanding of the purpose of the questionnaire, which had an influence on the 
feedback given. This was however addressed by conducting a second round of the Delphi 
technique and gaining consensus.  
Internal validity was addressed by having standardized instructions for the 
researcher-administered questionnaire (McLeod, 2013). External validity can be 
improved by setting experiments in a more natural setting (McLeod. 2013) and this was 
implemented by having the questionnaire administered in a room the participants use 
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                                                 Ethical Considerations 
The Declaration of Helsinki (World Medical Association, 2008) was used as a 
guideline for ethical considerations in this study. The following ethical principles were 
upheld at all times: autonomy, confidentiality, beneficence, non-maleficence and justice. 
Autonomy  
The right to self-determination is based on the principle of respect of individuals 
and their ability to control their own destiny (Houser, 2012; Polit & Beck, 2008).  This 
follows the notion that all people should be awarded a basic level of human dignity 
(Smith, 1999). All participants, including patients who refused to take part in the study, 
were treated with dignity and respect. Participants were made aware of all relevant 
information before being asked for consent. Specific to Aim 2, a research letter 
explaining the study was given prior to asking for consent. An option to withdraw from 
study without repercussions was also given to the participants. Proxy consent was not 
sought for those with dementia or similar illnesses (Pope & Sellers, 2012).  
 
Confidentiality  
This principle was maintained throughout the study. For the retrospective record 
review all the identifying information was removed when storing the data on the 
computer. No personal or demographic identifying information was included on the 
questionnaires. Initially the only foreseeable threat to confidentiality was with regards to 
the clinic being easily identified after writing up the results of the study but not a threat to 
the individuals themselves. The facility could therefore come under an unflattering light 
and if it can be identified due to lack of other facilities this could be a problem. At the 
moment, the ototoxicity monitoring programme has been decentralised only into the 
Khayelitsha community. The data collection was however, performed at more than one 
site, therefore addressing the initial threat to confidentiality. At the provincial level, plans 
to fully decentralise MDR-TB management service delivery are still being considered 
(Western Cape Government, 2011). If implemented while the findings of this study have 
not been released then the threat to confidentiality would also be automatically addressed. 
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Codes were used to identify participants with the retrospective record review as well as 
questionnaires administered.  
Poor urban populations such as Khayelitsha are commonly cited as being 
vulnerable groups (Van Ryneveld, Parnell & Muller, 2003). Initially the impact of being 
a vulnerable group was going to be amplified via self-administering the questionnaire as 
participants might have felt too intimidated to fill in the questionnaire. Since the 
questionnaire had to be verbally administered, this threat was addressed. The researcher 
however, still reassured the participants of their right and decision to withdraw from the 
study at any point and their treatment would not be affected.  The population in which the 
study was conducted is also arguably over-researched too, because of the unique 
characteristics they have that are distinctive and particularly interesting for researchers 
(Denny & Grady, 2007). Minimal risk was posed to the participants since they were 
required to answer a verbally administered questionnaire. The indirect benefit they got 
was that the responses they gave would then be used to advocate and improve the service 
delivery system. 
Beneficence  
Beneficence involves making an effort to secure the wellbeing of participants 
(Houser, 2012). It is hoped that the findings of this study will help in improving service 
delivery for ototoxicity monitoring by eliminating some of the barriers noted. Participants 
received airtime vouchers at facility 2 as a token of appreciation, after taking part in the 
study. The airtime was not intended to be used as a method of coercion.     
Non-maleficence  
Non-maleficence is not doing harm to the participants (Houser, 2012). Care was 
taken to ensure that the nurses would not know who participated in the study; in order to 
prevent participants from being victimised if the nursing staff issues were highlighted as 
a possible reason for non-adherence. An effort was also made to ensure that the 
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Justice  
Justice refers to the participants’ rights to fair treatment and fairness in 
distribution of benefit and burden (Houser, 2012). Claims of over-researching are likely 
to be reported in contexts where repeated engagements do not lead to any experience of 
change (Clark, 2008). All MDR-TB patients at the facility had an equal chance to take 
part in this study. The findings of this study will therefore be disseminated to the 
facilities, provinces and through publications, in order to bring about the change that is 
needed to improve service delivery in this community, and in so doing fulfil a form of 
distributive justice. There is a need for researchers in developing countries to fulfil an 
advocacy role (International Council of Nurses, 2008) as this would indirectly include the 
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Chapter Four: Results 
Introduction: Findings of the study will be presented according to its aims and 
objectives. The first section of the chapter will present the results regarding the pattern of 
service utilisation based on a retrospective review of patient records. Then the outcomes 
of an exploratory survey conducted to find out facilitators and barriers to the use of 
ototoxicity monitoring services for outpatients will be described. 
Phase One: Pattern of Service Utilisation  
Phase one focused on the pattern of utilisation of available ototoxicity monitoring 
services using a retrospective patient record review. The influence of the following 
factors on patterns of utilisation was investigated:  
(1) The area from which the patient was referred (proximity). 
(2) The MDR-TB treatment regimen prescribed for the patient. 
(3) The time from inclusion in MDR-TB programme to first audiologic assessment 
(waiting period).  
(4) The hearing status at the time of the initial hearing test. 
(5) Development of hearing loss during the course of treatment and  
(6) The presence and/ development of disabling hearing loss.    
Patients’ Description 
A total of 860 patient files were reviewed; 59 were deemed ineligible because 
there was missing information pertinent to the study such as the treatment regimen, date 
when MDR-TB treatment was implemented in order to establish the waiting period or 
demographic information. This left a total of 801 patient files which met the inclusion 
criteria and therefore were included in this study. A total of 415 (51.8%) males and 386 
(48.2%) females participated in the study, with the mean age being 37 [range 7 – 85] 
years.  The variables below were generated for the purpose of data analysis and show the 
frequency count of each variable (refer to Table 1).  
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Variables  (N=801) 
Referral Area (Proximity)  
City Bowl 13 (1.6%) 
Northern Suburbs 167 (20.9%) 
Atlantic Seaboard  24 (3%) 
Southern Suburbs 43 (5.4%) 
South Peninsula 23 (2.9%) 
Cape Flats 334 (41.8%) 
Helderberg 23 (2.9%) 
West Coast 142 (17.8%) 
Cape Winelands 27 (3.4%) 
Eden 3 (0.4%) 
Central Karoo 1 (0.1%) 
Treatment Regimen  
Kanamycin 689 (86.1%) 
Kanamycin and Streptomycin 15 (1.9%) 
Streptomycin 30 (3.8%) 
Others 66 (8.2%) 
Hearing Status  
Normal hearing (≤25dB HL) 397 (49.6%) 
Hearing loss (≥26dB HL) 404 (50.4%) 
Development of hearing loss 
(ASHA criteria) 
315 (64.3%) 
No development of hearing loss  175 (35.7%) 
Disabling hearing loss (WHO 
criteria) 
139 (17.4%) 
No disabling hearing loss 661 (82.6%) 
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Figure 2 shows the time it took patients to attend the initial hearing test and is 
broken down into four categories. The majority of patients (65.3%) took between one 
month and three months to have their initial hearing test conducted.  
                   
 
Figure 2: Time from inclusion in the MDR-TB programme to the first audiologic 
assessment (waiting period). 
 
Pattern of Attendance 
Minimal attendance was described as having between 1-3 visits and regular 
attendance being 4-6 visits. The overall pattern of utilisation showed that a total of 76% 
patients had minimal attendance for their hearing test appointment (i.e. had between 1-3 
visits) and only 24% had attended regularly (i.e. between 4-6 visits) (see Figure 3). 
Patients who only attended their first appointment and did not return for subsequent 
appointments were 39.1%.  Of those who attended initially, less than ten percent (9.1%) 






Time from inclusion in programme to first 
audiologic assessment 
Within one month 
> 1 months but < 3 
months 
>3months but  < 6 
months 
>6months 
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Figure 3: Frequency of attendance 
Pattern of Attendance as a Function of Hearing Status 
The majority of patients had minimal attendance (i.e. 1-3 visits) and Table 2 
shows the number of patients in each hearing status group. For those that utilised the 
services at least twice, the development of hearing loss was assessed using the ASHA 
(1994) criteria.  
Table 2: Pattern of attendance as a function of hearing status 
 n 1-3 visits 4-6 visits 
Normal hearing (≤25dBHL) 397 317 (79.9%) 80 (20.1%) 
Hearing loss (≥ 26dBHL) 404 293 (72.5%) 111 (27.5%) 
Development of hearing 
loss (ASHA criteria) 
315 173 (54.9%) 142 (45.1%) 
No development of hearing 
loss 
175 127 (72.6%) 48 (27.4%) 
Disabling hearing loss 
(WHO criteria) 
139 78 (56.1%) 61 (43.9%) 
Non-Disabling hearing 
loss 
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Pattern of Attendance as a Function of Referral Area 
The following areas would be considered outside the Cape Metropole area 
therefore requiring a substantial travelling distance to the central TB facility: Helderberg, 
West Coast, Cape Winelands, Eden and Central Karoo. Table 3 shows the attendance 
according to the referral areas. The majority of the patients had minimal attendance with 
the exception of those from the City bowl area, whose majority fell into regular 
attendance (i.e. between 4-6 visits) suggesting that close proximity to health care services 
facilitate utilisation. 
 



















 n 1-3 visits 4-6 visits 
City Bowl 13 4 (30.8%) 9 (69.2%) 
Northern Suburbs 167 129 (77.2%) 38 (22.8%) 
Atlantic Seaboard  24 18 (75%) 6 (25%) 
Southern Suburbs 43 35 (81.4%) 8 (18.6%) 
South Peninsula 23 18 (78.3%) 5 (21.7%) 
Cape Flats 334 268 (80.2%) 66 (19.8%) 
Helderberg 23 21 (91.3%) 2 (8.7%) 
West Coast 142 99 (69.7%) 43 (30.3%) 
Cape Winelands 27 17 (63%) 10 (37%) 
Eden 3 1 (33.3%) 2 (66.7%) 
Central Karoo 1 0 (0%) 1 (100%) 
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Pattern of Attendance as a Function of Treatment Regimen, Waiting Period and Sex 
The pattern of attendance was assessed within each treatment regimen category, 
waiting period and sex. The same pattern of minimal attendance was observed with the 
majority of the patients in all the categories (see Table 4).   
Table 4: Pattern of attendance as a function of treatment regimen, waiting period and sex  
 n 1-3 visits 4-6 visits 
Treatment 
Regimen 
Kanamycin 689 524 (76%) 165 (24%) 
Kanamycin & 
streptomycin 
15 11 (73.3%) 4 (26.7%) 
Streptomycin 30 26 (86.7%) 4 (13.3%) 
Other 66 48 (72.7%) 18 (27.3%) 
Waiting 
period 
Within one month 124 77 (62.1%) 47 (37.9%) 
0-3 months 379 282 (74.4%) 97 (25.6%) 
4-6 months 59 50 (84.8%) 9 (15.2%) 
>6 months 18 14 (77.8%) 4 (22.2%) 
Sex Males 415 320 (77.1%) 95 (22.9%) 
Females 386 290 (75.1%) 96 (24.9%) 
 
Generalised Linear Model: Relative/Risk Ratio 
Relative risk estimation by log-binomial regression using generalised linear 
modelling was used as inferential statistics for analysis. From the results obtained, 
variables that were statistically significant had a p-value <0.05 and an RR value < 1 for 
any specific variable indicated less likelihood of attendance of a hearing test appointment 
when compared to the  reference variable. An RR value greater than 1.0 indicated more 
likelihood of attendance when compared to the reference variable. The following 
variables were found to influence attendance: proximity (referral area), waiting period, 
pre-existing hearing loss at initial audiological assessment, development of ototoxic 
hearing loss and the presence and development of disabling hearing loss (see Table 5).  
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In terms of referral area (i.e. proximity), it was found that in comparison to the 
reference referral area (City Bowl), those who lived in the following referral areas: 
Northern Suburbs, Atlantic Seaboard, Southern Suburbs, South Peninsula, Cape Flats, 
Helderberg, West Coast and Cape Winelands were less likely to attend the hearing test 
appointment.  
For the waiting period, it was found that when compared to those who attended a 
hearing test within a month (reference waiting period), patients who took between 1-3 
months after being diagnosed with MDR-TB to attend their initial hearing test 
appointment were 0.3 times (30%) less likely to attend their hearing test appointment. 
Patients who took between 3-6 months were 0.6 times (60%) less likely to attend. It was 
generally found that the longer the time taken to attend the first hearing test, the less 
likely patients were to utilise the services.  
Regarding hearing status, compared to those with a hearing loss at baseline 
(reference category), those with normal hearing were 0.3 times (30%) less likely to attend 
(RR 0.7, p-value 0.02).  Those who had developed hearing loss during the course of 
treatment were 0.6 times (60%) [RR 1.6, p-value 0.0] more likely to attend when 
compared with those who did not develop hearing loss (reference category). Patients 
without disabling hearing loss (reference category), when compared with those who had a 
disabling hearing loss were 1.2 times (120%) [RR 2.2, p-value 0.0] more likely to attend 
than those without a disabling hearing loss (reference category). Pre-existing hearing 
loss, development of a hearing loss as well as disabling hearing loss were therefore 
motivating factors in influencing attendance.  
The following variables were not statistically significant therefore did not 
influence the utilisation of ototoxicity monitoring services: age, sex and treatment 
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Table 5: Predictors of regular attendance (i.e. 4-6 visits) 




RR (95% CI) 
Referral Area 
(Proximity) 
City Bowl 13 69%  1.0 (ref) 
 Northern 
Suburbs 
167 23% 0.00 0.3(0.2-.05) 
 Atlantic 
Seaboard 
24 25% 0.01 0.3(0.2-0.7) 
 Southern 
Suburbs 
43 18.6% 0.00 0.2(0.1-0.5) 
 South Peninsula 23 21.7% 0.01 0.3(0.1-0.7) 
 Cape Flats 334 19.8% 0.00 0.3(0.2-0.4) 
 Helderberg 23 8.7% 0.00 0.1(0.02-0.5) 
 West Coast 142 30.3% 0.00 0.4(0.3-0.6) 
 Cape Winelands 27 37% 0.03 0.5(0.3-0.9) 
 Eden  3 66.7% 0.9 0.9(0.4-2.1) 
 Central Karoo 1 100%    
Treatment 
Regimen 
Kanamycin 689 24%  1.0 (ref) 
 Kanamycin & 
streptomycin 
15 26.7% 0.8 1.1(0.5-2.6) 
 Streptomycin 30 13% 0.2 0.5(0.2-1.4) 
 Other 66 27.3% 0.5 1.1(0.8-1.7) 
Waiting 
period 
Within one month 124 37.9%  1.0 (Ref) 
 0-3 months 379 25.6% 0.007 0.7 (0.5 – 0.9) 
 4-6 months 59 15.3% 0.005 0.4 (0.2 – 0.8) 





404 27.5%  1.0 (ref) 
 Normal hearing 
(≤25dBHL) 




No change 175 27.4%  1.0 (ref) 
 Change 315 45.1% 0.00 1.6 (1.3 – 2.2) 
Disabling HL No  661 19.7%  1.0 (ref) 
 Yes 139 43.9% 0.00 2.2 (1.7 – 2.8) 
Age 7-29 239 23%  1.0 (ref) 
 30-39 232 21% 0.5 0.8(0.6-1.2) 
 40-49 189 26% 0.5 1.1(0.8-1.6) 
 50-71 141 28% 0.2 1.2(0.9-1.7) 
Sex Male 415 22.9%  1.0 (ref) 
 Female 386 24.9% 0.6 1 (0.8-1.4) 
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In conclusion, the following variables were statistically significant in influencing 
the utilisation of services; referral area (close proximity), presence of pre-existing hearing 
loss (≥26dB HL) at the initial audiologic assessment, development of hearing loss as well 
as the presence and/ development of disabling hearing loss. The following variables were 
however, not statistically significant and therefore did not have any influence with 
regards to attendance: age, sex, waiting period of over six months and treatment regimen. 
In addition, a waiting period of more than one month predicted the likelihood of minimal 
attendance.   
Phase Two: Facilitators and Barriers to Service Utilisation 
The aim for this phase was to explore factors that are facilitators of and barriers to 
the use of ototoxicity monitoring services using a survey conducted at two facilities 
where such services are available, viz., a central TB hospital (Facility 1) and a 
community clinic setting (Facility 2).  
Participant Description 
The questionnaire was administered to a total of 74 participants. All participants 
were MDR-TB patients attending the facilities for outpatient services. Six individuals did 
not give consent to participate in the study. More details of the characteristics of the 
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Table 6: Summary of participants’ description  
 Facility 1 
(N = 31) 
Facility 2 
(N=43) 
 n  Percentage n Percentage 
Gender (female) 15 51% 23 53% 
               (male) 16 49% 20 47% 
Age distribution in 
years 
    
18-29.9 12 38% 16 37% 
≥30 19 62% 27 63% 
Educational status     
Below  Grade 12    56% 37 84% 
Grade 12 and 
higher 
 28% 6 16% 
Time on Treatment     
less than 6 months 7 23% 13 30% 
6 months to 1 year 12 39% 15 36% 
1 to 2 years 11 36% 14 32% 
2 to 3 years 1 2% 1 2% 
 
Participants’ Questionnaire Results  
Question 1 asked participants whether they have ever missed their hearing test 
appointment since initiation of treatment. Out of all the 74 participants, 11 participants 
(15%) reported “Yes” thus indicating that they have missed at least one hearing test since 
treatment initiation.  
Possible reasons that may lead to participants missing an appointment were 
explored in questions 2a-2d. The reasons stated on the questionnaire were mainly 
logistical issues that were thought to be important for influencing a patient’s decision to 
attend or not attend a hearing test e.g. transport costs, difficulties taking time off work, 
being sick due to side effects from medications and long queues at the facility. Most 
participants indicated that logistic issues were not a barrier to the use of ototoxicity 
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monitoring services (see Figure 4). The majority of participants (98%) were not 




Figure 4: Possible reasons that may lead to missing an appointment at Facility 1 (F1) and 
Facility 2 (F2)  
Question 2e was open-ended and it explored if there was any other reasons one 
would miss their hearing test appointments. These reasons were noted to be having an 
appointment clash for co-existing ailments or for grant processing and/ mixing up of 
dates, being hospitalized or the patient was sick, and last, personal attitude: thinks the 
hearing is fine so does not need to have their hearing tested. Only one participant 
highlighted each barrier.  
Questions 3-4 dealt with participants’ attitude to the use of ototoxicity monitoring 
services. At Facility 1, a total of 71% of the participants both disagreed and strongly 
disagreed to the statement that “one only needs to have their hearing tested if they felt 
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Figure 5: Participants’ attitude regarding the need for hearing test 
 
At Facility 2 the participants agreed (both strongly agree and agree) to question 3 
that they only need to have their hearing tested if they feel deaf, whereas in question 4 
(see Figure 6), they also agreed that having their hearing tested is as important as taking 
their TB medication. When asked “taking TB medication was as important as having 
their hearing tested” (question 4), 84% of the participants agreed that taking TB 
medication was as important as having their hearing tested (see Figure 6).  
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F1 
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Questions 5 and 6 dealt with the interaction between nurses and MDR-TB 
patients. Most of the participants disagreed with the statement that nurses at the facility 
were rude (see Figure 7 for responses to question 5 (participants’ attitude [Q5]). 
   
Figure 7: Responses to the nurses being rude at facility 1(F1) and facility 2 (F2) 
 
All of the participants 100% at Facility 1 reported that the nurses are friendly and 
helpful with 63% of the participants stating the same at Facility 2 for question 6. 
Participants further reported that even if the nurses are rude, that will not deter them from 
getting the services they need from the clinic. 
Questions 7-9 dealt with beliefs. The highest frequency counts of the responses 
fell into the ‘disagree and strongly disagree’ category meaning that the participants were 
aware that if they acquire a hearing loss it is because of the ototoxic medication. At both 
facilities, similar responses were obtained where the cause for hearing loss was not 
ascribed to supernatural causes. Figure 8 shows the responses obtained regarding the 
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Figure 8: Beliefs concerning hearing loss 
Question 10 asked if the participants thought the hearing loss would resolve after 
finishing the TB treatment. The findings showed that 71% of the participants at Facility 
1, and 63% of the participants at Facility 2, thought that the hearing loss is reversible 
after finishing the TB treatment (see Figure 9).  
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Table 7 shows a summary of frequency count obtained for each question with the highest frequency count in bold 
Table 7: Frequency count of questionnaire responses (F1 N=31; F2 N=43) 
Question Strongly Agree Agree Disagree Strongly Disagree 
 F1 F2 F1 F2 F1 F2 F1 F2 
2a (taxi costs) 0 (0%) 5 
(12%) 
1 (3%) 2 (5%) 0 (0%) 30 (70%) 30 (97%) 6 (14%) 
2b (time off work) 0 (0%) 1 
(2%) 
0 (0%) 0 (0%) 1 (3%) 30 (70%) 30 (97%) 12 (28%) 
2c (sick) 0 (0%) 1 (%) 2 (6%) 6 (14%) 1 (3%) 31 (72%) 28 (90%) 5 (12%) 
2d (long queues) 1 (3%) 7 
(16%) 
0 (0%) 2 (5%) 8 (26%) 32 (74%) 22 (71%) 2 (5%) 






1 (3%) 33 (77%) 3 (10%) 0 (0%) 19 (61%) 0 (0%) 






1 (3%) 16 (37%) 0 (0%) 1 (2%) 5 (16%) 1 (2%) 
5 (nurses rude) 1 (3%) 1 
(2%) 
0 (0%) 5 (12%) 0 (0%) 26 (60%) 30 (97%) 11 (26%) 




0 (0%) 21 (49%) 0 (0%) 7 (16%) 0 (0%) 2 (5%) 






3 (10%) 1 (2%) 2 (6%) 24 (56%) 16 (52%) 17 (40%) 






0 (0%) 1 (2%) 4 (13%) 17 (40%) 23 (74%) 24 (56%) 
9 (HL due to 
bewitchment) 
1 (3%) 2 
(5%) 
2 (6%) 1 (2%) 0 (0%) 11 (26%) 28 (90%) 29 (67%) 






2 (6%) 16 (37%) 4 (13%) 13 (30%) 5 (16%) 3 (7%) 
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Gender-Based Differences in Service Utilisation for Questions 2-10  
Due to a small sample size and relatively homogeneous study sample,  gender 
differences in utilisation patterns was the only variable that was investigated. The 
difference between males and females’ responses to question 1 which asked the 
participants if they had missed a hearing test appointment before, was analysed using 
Fisher’s exact test. A p<0.05 was considered significant. The results showed that there 
was no significant difference in appointment attendance between males and females 
(p=0.394 and p=0.544 ) for facility 1 and 2 respectively.  
The Mann-Whitney U test was used in order to determine if there is any 
difference between males and females in the utilisation of the ototoxicity monitoring 
services for questions 2-10. A p <0.05 was considered statistically significant. For all the 
questions at both facilities, a p-value greater than 0.05 was obtained meaning there was 
no significant difference between gender in the utilisation of the ototoxicity monitoring 
services. Overall service utilisation was similar between males and females. 
In summary, the results of phase two showed that overall, facilitators for 
utilisation of services were as follows: close proximity to the health facility, good 
interaction with the TB nurses and understanding the importance of monitoring the 
hearing due to the ototoxic effects of TB medication. 
Barriers reported by the participants included: appointment clash for co-existing 
ailments or for grant processing and/ mixing up of dates, being hospitalized or the patient 
was sick and personal attitude: thinks the hearing is fine so does not need to have their 
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Chapter Five: Discussion 
Introduction: This chapter will present a discussion of the findings of the study in 
relation to existing research literature. Study recommendations and implications for 
future research will then be explored. 
The findings of this study showed that the majority of participants under-utilised 
available services for ototoxicity monitoring when accessed on an outpatient basis. 
Specific to phase one, the overall pattern of utilisation showed that a total of 76% patients 
had minimal attendance for their hearing test appointment (i.e. had between 1-3 visits) 
and only 24% had attended regularly (i.e. between 4-6 visits). The study also found that 
about 39% of patients attended only the initial hearing test appointment. The pattern 
therefore shows that of those who enter the ototoxicity monitoring programme, roughly 
three quarters of them dropped out within the first three visits. The ototoxicity monitoring 
programme being offered is therefore only effective and reaching its potential for one in 
four participants. The reality could be even worse since it is not known how many 
patients were referred and did not attend the initial hearing test appointment.  
Only about 10% of the patients attended all of the first six hearing test 
appointments. Six visits is the minimum number of visits expected for any patient being 
treated with long-term ototoxic injectable aminoglycoside (especially kanamycin) for 
MDR-TB (Duggal & Sarkar, 2007; TB Alliance, 2015) in order to monitor the hearing. 
An ideal scenario however would be to continue to monitor hearing throughout the 
treatment course and then for up to six months thereafter due to the propensity for 
ototoxic hearing loss to continue to progress even once the drug has been withdrawn 
(Duggal & Sarkar, 2007).  
Given that patients who were receiving MDR-TB treatment were enrolled in the 
DOTS strategy for TB treatment, it was expected that most of these patients would use 
available services including ototoxicity monitoring, particularly once such services had 
been devolved to local community-based facilities. DOTS strategy has been reported to 
improve the likelihood for adherence to treatment recommendations (Western Cape 
Government, 2014; MSF, 2011), however, it was found that patients in this study did not 
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utilise ototoxicity monitoring services. Previous reports have raised concerns that while 
the DOTs programme has been widely implemented, too often the emphasis has been on 
simply observing patients taking medication, and not enough on true support which is 
required to care for people with serious, chronic and life-threatening diseases (Achmat & 
Roberts, 2006). Patients need to be  empowered especially those who have come from a 
patriarchal system of medicine and who are likely from a different linguistic, cultural and 
socio-economic status from the person providing care (Achmat & Roberts, 2006).  
While the results suggest that patients do not sustain their attendance and use of 
ototoxicity services, it remains unknown how many patients fail to enter the audiologic 
system at all. If patients do not attend the initial hearing test, any pre-existing hearing loss 
will be missed; thereby increasing the risk for developing ototoxic deterioration of 
hearing (Duggal & Sarkar, 2007; ASHA, 1994) as well as depriving the treating health 
care practitioner of this important information. If the initial appointment is missed, 
patients may not know how to access services should a hearing loss develop, therefore 
leaving disability unaddressed. There are a number of factors which may impact 
adherence, of which patient-related factors are just one determinant. WHO (2014) 
suggested that the common belief that patients are solely responsible for 
adherence/service utilisation is to be dispelled. WHO (2014) highlighted five interactive 
dimensions that affect adherence in healthcare service utilisation and all these five areas  
require in depth exploration to reveal possible  reasons for under-utilisation of ototoxicity 
monitoring services. As explored in the literature review, the five dimensions are: 
social/economic-related factors, health care team and system-related factors, condition-
related, therapy-related and patient related factors. The next section of this discussion will 
discuss these dimensions and how they influence ototoxicity monitoring service 
utilisation.  
Several factors were found to be significant in influencing patients’ patterns of 
utilisation of ototoxicity monitoring services. These involved health care system-related 
factors: proximity to the health facility, a shorter waiting period between treatment 
initiation for MDR-TB and the first audiologic assessment, good interaction with the TB 
nurses and understanding the importance of monitoring. Patient-related factors included: 
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patients being hospitalised, appointment clashes and a personal attitude where a patient 
thinks their hearing is fine therefore does not need to make use of ototoxicity monitoring.  
Condition-related factors were also noted such as hearing status at the time of treatment 
initiation, development of ototoxic hearing loss during treatment and disabling hearing 
loss.  
Health care system and team-related factors 
Logistics. Close proximity facilitates utilisation of healthcare services, while 
conversely distance may act as a barrier when services are remote from where the 
individuals reside (Nteta et al., 2010). Evidence from this study revealed that greater 
travelling distance brought a 90% chance likelihood of non-use of ototoxicity monitoring 
services which supports the documented report by Nteta et al. (2010). A noticeable 
difference in the pattern of utilisation was expected with referral areas that were closer to 
the central TB hospital (i.e. Northern Suburbs) showing markedly better adherence than 
those who were referred from further areas outside the Cape Metropole such as Cape 
Winelands. The lack of a noticeable difference for patients referred to Facility 1 could 
therefore be because of the lack of motivation or awareness specific to ototoxicity 
monitoring services considering that close proximity is a facilitator of service utilisation 
with other health related issues.  
Specific to phase two, hospitalisation and appointment clashes were noted on 
individual basis as barriers. Appointment reminders can be of help to such individuals 
and an alternative dates can be set in case of a patient being hospitalised. In addition, an 
open door policy can also be incorporated where patients can come to the clinic any day, 
with or without an appointment since the patients are expected to come daily for DOTS. 
Patients with life threatening diseases, such as, children with HIV, have a no ‘wrong day’ 
policy which has been found to be effective in treating the disease (Helping our Women, 
2015). 
Other logistic issues such as cost of transportation, taking time off work, being 
sick and waiting in long queues were thought to have the potential to influence the uptake 
of ototoxicity monitoring services. Contrary to the expectations from the literature 
review, this was however not borne out by the results.  Certain authors suggested the 
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above logistic factors as barriers in service utilisation (Freitas et al., 2012; Nteta et al., 
2010). Participants in this study however, revealed that these logistic factors did not 
affect them as the health care services were within close proximity. Some participants 
from facility 1 who resided outside the Cape Metropole were provided with transport in 
order to attend their ototoxicity monitoring service appointments. In addition, most of the 
participants were unemployed therefore taking time off work was inapplicable. For those 
who were employed, they were issued with a sick leave certificate which was effective 
for the duration of the treatment. Hess (2009) suggested that there is a need to develop 
unorthodox service provision locations as well as the provision of appointment times that 
are suitable to the workers’ needs. He further stated that interventions such as reducing 
wait times, providing meaningful incentives and the renovation of disease specific 
educational approaches may improve outcomes.  
Waiting period. Delays in the waiting period in accessing services implied that 
the longer the time taken to attend the first hearing test, the less likely patients were to 
utilise the ototoxicity monitoring services. Establishment of hearing thresholds within the 
recommended 72 hours of drug administration (WHO, 2010) serves two purposes.  First, 
to define any pre-existing hearing loss which is a risk factor to further deterioration as a 
result of aminoglycoside exposure; and second, to establish a baseline which enables 
comparison with subsequent tests to evaluate if ototoxicity has occurred (Durrant et al., 
2009).  Important information may be unavailable to health care practitioners who are 
providing the treatment if the time period of one month is exceeded (Duggal & Sarkar, 
2007; ASHA, 1994). It is also more feasible, in a hospital or centralised setting, to 
monitor inpatients and ensure the initial hearing test is conducted within the stipulated 
timeframe but it is not as practical to monitor outpatients (Department of Health, 2011; 
MSF, 2011). When compared with the reference category of attendance within one 
month, (ASHA, 1994; WHO, 2010); attendance was found to be 30% less likely for 
patients who took between one to three months to attend. Those who took between three 
and six months to attend had a 60% less chance of doing so.  
The reasons for better adherence among patients who utilised the ototoxicity 
monitoring services promptly could be that individuals had already noted a hearing loss 
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which is associated with self-perceived limitations; social pressure or support exerted by 
significant others, or willingness to engage with rehabilitation services (Duijvestijn et al., 
2003; Meyer & Hickson, 2012). It is also possible that participants who delayed 
accessing audiologic services may not have developed hearing loss or been aware of 
having a hearing loss and thus not valued the importance of monitoring; rather they 
elected to wait until they became aware of symptoms. It is however possible, that a high 
frequency hearing loss typical of the initial stages of ototoxicity (Valete-Rosalino & 
Rozenfeld, 2005) may not have been disabling to patients.  It is described in the literature 
(Fallabi-Stubi et al., 1998) that patients seek assistance when symptoms become 
problematic for them. It is therefore possible that a discrete high frequency hearing loss 
or even the onset of tinnitus may not push patients facing life-threatening illness across 
the threshold towards consultation specific to otological symptoms. However, in this 
study, high frequency audiometry was not conducted. Another possible reason could 
however lie in the way the system is structured i.e. one actually has to enter the system 
first in order to utilise it by getting subsequent appointments. Those who would have 
faltered would therefore not know how to re-enter the system.  
The structure of the healthcare system e.g. referral system, might therefore also be 
a possible reason for the delay in the initial utilisation of ototoxicity monitoring services. 
Nkosi et al. (2013) in their study of factors influencing referral of MDR and XDR-TB 
patients showed that a considerable number of patients got deceased in the interval 
between diagnosis and referral. This highlights the importance of a stringent follow up, 
timely and effective referral system for this extremely vulnerable patient group. At 
Facility 1, one had to enter into the system in order to subsequent audiologic 
appointments. Therefore if an individual misses the first appointment he/she is effectively 
exited from the system. Nkosi et al. (2013) gave a possible explanation for referral 
problems occurring on staff level stating that there may be a considerable level of staff 
rotating through rather than ‘TB staff’ being permanently in their positions; to what 
extent this is a contributing factor would remain to be elucidated. Furthermore, there are 
high levels of attrition in nursing in this country leaving many unfilled posts (Nkosi et al., 
2013). The lack of permanent ‘TB staff’ could therefore be another possible reason for 
lack of follow up on patients as seen with 39% of the patients attending only their first 
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audiologic assessment, but this assumption cannot be drawn from this study. Dedicated 
staff would therefore need to track attendance and get patients back into the system if 
they fall out. Since the audiologists are the ones responsible for managing the ototoxicity 
monitoring programme, support of non-attenders by the new Audiologists appointed in 
the TB programme in the Western Cape will then be a crucial role. Effective and accurate 
flow of information between the central TB hospital and the clinics from which patients 
are referred, which incorporate the DOTS strategy, is thus paramount in ensuring 
effective uptake of services in a timely manner.  
Support networks. Prior to this study it was thought that the attitude of health 
care professionals with whom the participants had encounters could either facilitate or 
obstruct adherence to ototoxicity monitoring. Nurse abuse of patients in South Africa has 
been described by Kruger and Schoombee (2010) as mentioned in the literature review. 
Other reports have raised concern about patients’ human rights being abused in South 
African hospitals (Vivian et al., 2011). Reports from Govender and Mash (2009) and van 
der Walt (2004) pertaining to the attitude of nurses towards TB patients revealed that 
similarities between nurses and the patients, in terms of race, income or educational 
background, led to fears about the nurses’ professional identities. Such concerns about 
the nurses’ role hampered their capacity to relate warmly and empathically with patients 
(van der Walt, 2004). Hess (2009) however, stated that treatment strategies that 
incorporate the cultural beliefs and practices of the population may narrow the service 
gap considerably (Hess, 2009). In contrast, the finding from the current study revealed 
little concern about the nurses’ attitude with respondents perceiving the nurses as helpful 
and friendly. Furthermore, patients indicated that their desire to ensure their wellbeing 
would not deter them should they face rudeness from nursing staff. Thus, these findings 
are positive and in contrast with reports in the literature that reflect badly on nurses 
dealing with TB patients in particular (Govender & Mash, 2009; van der Walt, 2004). In 
addition, the experiences reported by patients are encouraging as support in treatment is 
part of the DOTS philosophy. It is noted that Facility 2 runs support groups to provide 
awareness, empowerment and care to the users of the facility which might have provided 
a platform for a positive impact to these individuals to utilising the services provided.    
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Patient-Related Factors  
Attitudes and beliefs. The attitude of an individual compounded with a lack of 
symptoms was noted in the literature as variables influencing service utilisation, as 
outlooks and beliefs greatly shape an individual’s behaviour (Levy et al., 2008). The 
healthcare system has given priority to treating MDR-TB in terms of public health issues 
such as preserving life and disease control over monitoring the hearing which is an 
individual and quality of life issue (Harris, Peer, et al., 2012). Participants in phase two, 
specifically from Facility 2 had the same attitude giving priority to treatment thereby 
acting as a barrier to service utilisation. Despite Facility 2 participants having support 
groups and counselling services in place, they however, responded that they should have 
their hearing tested only if they felt deaf. This attitude could be due to the lack of 
symptoms in that the effects of hearing loss are not usually immediately apparent. 
Patients thus cannot appreciate the perceptible benefit of monitoring their hearing and are 
less likely to adhere to the programme despite the recommendations made during 
counselling (Moore, 2012). Shaikh and Hatcher (2004) concurred by noting that the type 
of symptoms experienced for the illness are major determinants of health seeking 
behaviour thereby implying that the less severe the condition seems to be, the less likely 
to utilise healthcare services.  
Second, beliefs in the supernatural or traditional healers and resignation towards 
hearing loss management were expected to influence utilisation in this study (Shelton et 
al., 2011). From the participants’ responses, a high awareness of the ototoxic effects of 
their medication was revealed by most participants therefore the influence of the 
supernatural as a cause of hearing loss in this study was not endorsed. Resignation 
towards hearing loss management also did not influence service utilisation as seen with 
better adherence of those with a hearing loss.  
     However, despite the high awareness and apparent understanding of ototoxic 
effects of MDR-TB medication, a large majority (71% Facility 1, 63% Facility 2) of the 
participants indicated their belief that the hearing loss will be reversible after completing 
their TB treatment. It is possible that the permanency and possible progression of the 
hearing loss as a result of treatment might be an aspect that is not stressed in patients’ 
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awareness education and the focus is more on the cause and monitoring.  Another reason 
could be that the information is given, but the participants do not retain the information or 
they are optimistic and think that the effects will be reversible. Schmidt von Wühlisch 
and Pascoe (2010) stated that patients in the health care sector frequently struggle to 
understand and remember details of clinical information and the reasons underlying their 
treatment. Realising from the onset that the hearing loss is permanent and possibly 
progressive will help in the patient being more open to rehabilitation options.  
The awareness of an irreversible hearing loss might however lead patients refusing to 
take the aminoglycosides thereby needing the much more expensive drugs thus adding 
onto the already costly MDR-TB treatment. Additional costs to treatment will have 
massive implications for developing countries.  As an ethical issue, patients should be 
made aware of the need to treat TB due to its pandemic nature and it being a threat in 
terms of public health; but also fair and open discussion regarding the possibility of 
hearing loss should precede the patients’ informed consent.  Finally there is a duty of care 
towards those who require audiologic rehabilitation to ensure this is high quality and able 
to return the patient to his or her pre-morbid lifestyle.   
Age. Age as a patient-related factor is reported to affect adherence, but 
inconsistently (WHO, 2014). Age was therefore expected to influence the pattern of 
utilisation. Findings from this study pertaining to age were not statistically significant but 
a trend was however observed. A clear trend emerged in phase one, with the patients in 
the age category of 40 years and above, being more likely to attend.  Patients aged 39 
years and younger were less likely to utilise the ototoxicity monitoring services. Reasons 
for this could be in line with the report made by WHO (2014) where older adults and the 
elderly are more likely to adhere to treatment because it is essential to their well-being 
(depending on the type of treatment) and is thus a critically important component of care. 
In addition the young adults’ poor adherence has been thought to be a reflection of 
rebellion against the regimen's control over their lives (WHO, 2014).  It may be that 
marketing ototoxicity monitoring packages has to be different from the way they are 
currently presented. Thus, different aspects of the advantages and importance of 
preserving hearing have to be highlighted, for example, having influential figures who 
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have had TB encouraging fulfilment of all aspects of the programme.  It is also possible 
that older adults, particularly from those who are arguably from disadvantaged 
backgrounds, may have previously experienced a more patriarchal health care system and 
thus follow instructions given by medical staff as they feel disempowered to do anything 
else (Achmat & Roberts, 2006). 
Vaidya et al. (2012) stated that there is a difference regarding health care service 
utilisation between males and females with a higher uptake in women. The results from 
the current study in both phases however, do not uphold this finding. For instance, from 
phase one, the total number of females differed with males by a minimal margin. 
Statistical analysis also showed no significant difference in the pattern of utilisation of 
the services. Specific to phase two, all the questions obtained a p-value >0.05 between 
sexes meaning the difference was not statistically significant at both the sites where the 
study was performed. In addition, a difference in how males and females responded to 
each question was expected but again, no statistically significant difference was obtained.  
Assumptions for these findings were not congruent with Vaidya et al.’s statement and this 
could be because the sample size was small therefore the discrepancy from what 
literature suggests. Another possible reason could also be due to the fact that for some 
types of health care services, women have higher utilisation rates than men (Gerritsen & 
Devillé, 2009). Ototoxicity monitoring therefore could be one of those types of services 
where there is no significant difference in service utilisation between genders. 
Condition Related Factors 
A significant patient-related factor that was found to influence patients’ patterns 
of utilisation of services in phase one, was the patients’ hearing status. Patients with 
hearing loss of ≥26dBHL at baseline, patients who developed hearing loss and those with 
disabling hearing loss were found to be more likely to use ototoxicity monitoring 
services. It is therefore possible that the medical staff made patients aware of the 
ototoxicity monitoring service and patients who noticed a change in their hearing status 
may have informed the medical staff, which prompted recommendations for ototoxicity 
monitoring. Furthermore, once medical staff and audiologists established that a patient is 
at a higher risk of hearing loss from ototoxic medication or their hearing is negatively 
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being affected by treatment, these patients were likely to be followed up more closely 
hence their high likelihood of returning for monitoring visits.  
It is also possible that patients who perceived their hearing to be negatively 
affected by the medications were more likely to seek help to prevent further deterioration 
of hearing. According to Meyer and Hickson (2012), the patient’s self-perception of 
hearing loss, in particular when it is at disabling levels, is likely to motivate him/her to 
seek help. Garstecki and Erler (1998), agreed with the previous studies mentioned by 
stating that individuals who had greater hearing loss adhered to services; thus supporting 
the notion that hearing loss, particularly when marked, is a motivating factor for 
adherence. Therefore the attendance could have been influenced by help-seeking 
behaviour in order pursue management options, and not simply to document the loss 
through monitoring. Individuals with normal hearing however, were less likely to attend 
their hearing test appointment. 
In summary, there are likely more barriers for outpatients than inpatients which 
need to be explored beyond the scope of this study bearing in mind that considerable 
expenses have been incurred with the roll-out of such services and there could be cost-
effectiveness implications. Investments were made through purchasing equipment and 
providing training at both facilities. Despite the services being available five days a week, 
under-utilisation of ototoxicity monitoring services is apparent. The political will to 
achieve the effective management of TB in the community is evident with the rollout of 
new and decentralised services and needs to be capitalised upon in order to prove its 
effectiveness. In so doing, evidence is given to support the decentralised programme to 
be replicated and expanded on. Despite close proximity shown to make a difference in 
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Study Limitations  
A limitation from phase one was based on the study design itself, in that 
information used for the review was recorded in the medical files for reasons other than 
the study, therefore, the reasons for under-utilisation could not be ascertained from the 
records. The pattern of utilisation was only described for Facility 1, access to Facility 2 
was not granted for the retrospective record review. In phase two, the patients who did 
not utilise the services at the clinic were not included in the survey yet they are the most 
ideal candidates to shed light on the actual barriers stopping them from utilising the 
services. The barriers noted were by those who have made use of the ototoxicity 
monitoring services previously. This was therefore a great limitation and could be 
rectified by going into the homes of patients who are on MDR-TB treatment but do not 
make use of the ototoxicity monitoring services and ascertaining their reasons or barriers. 
Community health workers who already assist patients in the form of the DOTS strategy 
can be equipped to explore the barriers during their interactions with the patients.  
 With regards to data analysis of the first aim, a standard pure tone average was 
used instead of high frequency PTA of 4, 6 and 8kHz which considers the configuration 
of the hearing loss was not included. This leaves out critical information since it is known 
that the higher frequencies are affected first by ototoxic medication. 
Another limitation was the small sample size used when administering the 
questionnaire in the second phase of the study. Inferential statistics could not be used in 
order to generalise the results to the population thereby providing an insight into service 
delivery improvement. In addition, changing the method of delivery of the questionnaire 
from being self-administered to being verbally administered was another limitation. The 
change meant that, the process of administering the questionnaire would be slower as 
each participant had to wait for their turn whereas self-administering meant more 
participants could fill in the questionnaire simultaneously thereby allowing more 
participants to be assessed at the same time. An increase in the Hawthorne effect was also 
more likely as a need by participants to give socially desirable answers (Polit and Beck, 
2008) or a cultural need to be polite and answer in the affirmative (Polit & Beck, 2008). 
Whereas, if the questionnaire was self-administered, participants’ chances of being 
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identified are less and so they can be more forthcoming. The final limitation was that the 
sample was not truly representative of the population since the majority of participants 
denied having missed an appointment making the results skewed by attendees rather than 
those with more sporadic attendance. 
Study Implications 
The major implication of this research suggests that policy guidelines should be 
put in place to ensure the efficiency and effectiveness of ototoxicity monitoring service 
delivery due to the under-utilisation of services. These guidelines would help to ensure 
that if similar services are implemented in future, the effect of barriers to the utilisation of 
current services will be minimized. In addition, the cost implications of having services 
that are under-utilised make it a very expensive service with a very poor yield. The 
implications will be discussed using the WHO framework below: 
 
Healthcare team and system-related factors. Some major barriers reported by 
WHO (2014) which are inextricably linked to health system and team factors are: 
 Lack of awareness and knowledge about adherence. 
 Sub-optimal communication between patients and health professionals. However 
in this study, a good interaction between the nurses and TB patients was found.  
More emphasis during counselling therefore needs to be given to the irreversible 
effects of hearing loss due ototoxic medication or possibility of acquiring hearing loss 
post-treatment, thus the need for continual monitoring. Although adherence interventions 
directed towards patients have typically focused on providing education to increase 
knowledge; available evidence shows that knowledge alone is not enough to influence 
adherence (Roter et al., 1998, as cited in WHO, 2014). Evidence from the current study 
suggests that understanding of the ramifications of ototoxicity is incomplete. This gap in 
comprehension, and the belief that the hearing loss is reversible, may have impacted 
negatively on the uptake of ototoxicity monitoring services.  
Flexibility in availing ototoxicity monitoring services at all times is recommended so 
that who do not keep the first appointment are not effectively exited from the system. The 
first six appointments can be written on a card and given to a patient upon diagnosis, that 
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way if s/he misses the initial appointment, there are subsequent dates provided which can 
be attended with the patient sure to be seen. In conjunction, prompts such as routine 
reminders for patients to keep pre-arranged appointments via SMS or sending letters can 
also be incorporated as an attempt to improve ototoxicity monitoring services. 
Community-based rehabilitation workers can also be made aware of patients in their 
districts and include them on their rounds to encourage compliance. 
Effective flow of communication along the referral pathway needs to be emphasized 
to ensure the right information is being provided to the patients as well as adequate 
follow up being implemented. This might imply having someone in charge of a central 
database which will make it easier to identify patients who do not utilise the ototoxicity 
monitoring services after being diagnosed and ensure continual monitoring even if a 
patient relocates. While the actual monitoring and screening services can and arguably 
should (Duggal & Sarkar, 2007) be devolved to ancillary personnel, the overall 
management is the responsibility of the audiologist.  Newly appointed audiologists in the 
employ of TB services in the Western Cape should be at the forefront in ensuring that the 
proposed guidelines for managing TB patients on aminoglycosides are implemented. The 
audiologist should spearhead patient management and ensure that patients who develop 
hearing loss receive the appropriate intervention and rehabilitation. However, while a 
national policy for MDR TB exists (Department of Health, 2011) the guidelines for the 
province have not yet been finalised.  
Social/economic related factors. The main economic and social concerns that should 
be addressed in relation to adherence are poverty, illiteracy, provision of effective social 
support networks and mechanisms for the delivery of health services that are sensitive to 
cultural beliefs about illness and treatment (WHO, 2014). Social support networks are 
already being provided using the DOTS strategy. MSF has however reported having 
success with the DOTS strategy (MSF, 2011). Therefore, assessment of social needs, 
providing social support, providing transport to treatment setting, peer assistance as well 
as incentives and reimbursements (money or in kind) to reimburse the expenses of 
attending the appointments, or to improve the attractiveness of the uptake of services can 
be implemented. Peer assistance will employ people from the same social group helping 
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someone with tuberculosis to return to the health centre by prompting or accompanying 
him or her. 
Patient-related factors. The major barriers to adherence described in the 
literature reviewed for the WHO 2014 report included difficulty with motivation and self-
efficacy.  Motivation, which drives sustainable good adherence, is however, one of the 
most difficult elements for the health care system to provide in the long term (WHO, 
2014). Although health professionals have an important role in promoting optimism, 
providing enthusiasm, and encouraging maintenance of health behaviours among their 
patients, the health systems and health care teams experience difficulties in constantly 
motivating patients with chronic conditions (WHO, 2014). A therapeutic relationship 
with the patient is therefore encouraged as an attempt to provide motivation, coupled with 
incentives and/or reinforcements as well as home visits for patients who do not utilise the 
ototoxicity monitoring services (WHO, 2014; TB Alliance, 2015).  
Recommendations  
Future Research 
Use of a qualitative design such as interviewing the patients who do not utilise the 
ototoxicity monitoring services as well as a longitudinal study, may reveal additional 
barriers not previously considered. The level of education can also be included to 
ascertain if it influences service utilisation. A larger sample size is also recommended so 
that the findings can be more generalisable as well as considering high frequency average 
when classifying ototoxic hearing loss. 
The pattern of service utilisation at Facility 2 can also be analysed in order to 
ascertain if the ototoxicity monitoring service is effective. In so doing, the variables that 
are predictors for attendance can also be noted and this information will be used in 
improving the service delivery to the patients.   
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          Policy and Practice Recommendations 
From the findings of both phases of this study, the following practices are 
encouraged in order to continue facilitating service utilisation for ototoxicity monitoring: 
bringing services closer to the community, increasing awareness regarding the effects of 
ototoxicity medication, ensuring that patients have their first audiologic assessment 
within a month of inclusion in the MDR-TB programme, understanding the importance 
of monitoring the hearing as well as the maintaining the apparent good relationships 
between nurses and MDR-TB patients. With regards to practice, use of high frequency 
audiometry is recommended during monitoring for early identification of ototoxicity and 
should be used as a standard. 
Conclusion 
This study showed that ototoxicity monitoring services that are provided on an 
outpatient basis are currently being under-utilised. Individuals at risk for developing 
ototoxic hearing loss, and there are local reports to suggest this occurs in high numbers, 
likely do not enter or are lost in the system due to lack of follow up. Individuals 
monitoring these patients must ensure that patients are identified as early as possible 
when they initiate treatment for MDR-TB treatment to avoid losing them. Research is 
needed to further elucidate other factors that may act as barriers against the maximal 
utilisation of the services. The barriers explored should not only be patient-related but the 
five interactive dimensions identified by WHO (2014) that affect adherence should be 
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Appendix A:  Data Collection Sheet 
Date of Review __________________      Age__________________________________ 
Sex _________________________       Place of referral/residence________________ 
Researcher ______________________      
Inclusion Criteria 
TB patient exposed to aminoglycosides on TB DOTS programme between   __________ 
(month, year) and ________________(month, year). 
Y___   N___ 
If No, this file is ineligible for this audit 
 
 
1. Treatment regimen 
____________________________________________________________ 
2. Initial hearing status 
___________________________________________________________ 
___________________________________________________________ 


















Apt3 Apt 4 Apt 5 Apt 6 
MDR-TB        
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Fax: +27(0) 86 611 0725 
Email: Christine.Rogers@uct.ac.za 
                           Lebogang.Ramma@uct.ac.za 




Title of the Study: Factors that influence the utilisation of ototoxicity monitoring 
programme 
Supervisor: Christine Rogers 
Co-Supervisor: Dr Lebogang Ramma 
MSc Student: Primrose Nhokwara 
Institution: University of Cape Town  
Introduction  
My name is Primrose Nhokwara. I am studying at the University of Cape Town. My 
supervisors are Christine Rogers and Dr Lebogang Ramma. For my study I want to find 
out what makes people come or not come for the hearing tests performed at the 
Khayelitsha (Site B and Site C) community health clinic (CHC) and Brooklyn Chest 
Hospital.  I would like to invite you to be part of this study. If you say yes, you need to 
read and understand what the study is about.  This letter will tell you what will happen. 
Please make sure you fully understand what is involved before you say yes. 
Ethical approval: This clinical study protocol has been submitted to the University of 
Cape Town, Human Research Ethics Committee (HREC) and written ethical approval 
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Purpose of the study: 
This clinic is able to test hearing when people are getting treated for TB.  We are trying 
to find out the reasons that make people come or not come for these tests. Since you 
come to this clinic, we think you might be able to tell us more about this as you are using 
this clinic for your TB treatment.  We want your opinion as a patient. This will help us to 
improve the current services provided. It will also help us when putting more of these 
services in other communities like this one. 
Study Procedures: 
The following will be expected of you when you decide to take part in the study: 
 You will be asked to go through a questionnaire and let us know of your opinions 
regarding your knowledge and experience of the hearing tests at the clinic. 
 The questions will be read to you and it will take about 5 minutes to answer the 
questionnaire. 
 If, however you are not able to proceed with the study for whatever reason, you 
are free to withdraw from the study. Your treatment at the clinic will not be 
affected in any way.  
 
Benefits:  
Airtime voucher will be given as a token of appreciation for taking part in our research 
project. Your participation will help us to improve delivering our services to you. The 
findings from this study will be presented to the Department of Health and the research 
participants via the notice board at the community clinic. 
Risks: 
There are no risks associated in taking part in this study. The information that you will 
provide through the discussion and feedback on the questionnaire will help the 
community by how changes can be made to deliver the hearing tests services currently 
being given. 
Costs:  
There are no costs involved. The study will be done on the days you are already 
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Confidentiality: 
Your privacy will be maintained during the study and when writing up the findings. The 
information provided on the questionnaire will be stored away in a locked cabinet where 
only my supervisors and I will have access to. Any identifying information will be 
removed when storing the feedback from the questionnaires on an Excel spread sheet on 
a password protected computer. 
 
Voluntary Participation:  
Taking part in this study is voluntary. If at any point you want to drop out from the study, 
you have the right to do so without your treatment being affected in any way. There will 
be no penalties for dropping out of the study. 
Questions: 
All questions related to this study can be forwarded to the following individuals: 
 
Primrose Nhokwara (Researcher)  
Cell: 073 827 6771                                                 Email: nhkpri001@myuct.ac.za 
Christine Rogers (Supervisor)  
Tel: 021 406 6315                                                 Email: christine.rogers@uct.ac.za 
Dr. Lebogang Ramma (Co-Supervisor)  
Tel: 021 406 6954   Cell: 073 153 3803                 Email: Lebogang.Ramma@uct.ac.za  
A/Prof. Mark Blockman (Chairperson)  
University of Cape Town, Faculty of Health Sciences, Human Research Ethics 






FACTORS INFLUENCING OTOTOXICITY MONITORING SERVICES            111 
 
Appendix F: Informed Consent Letter  
                 School of Health and Rehabilitation Sciences 
Faculty of Health Sciences 
Divisions of Communications Sciences and 
Disorders, Nursing and Midwifery, 
Occupational Therapy & Physiotherapy  
F45 Old Main Building,  
Groote Schuur Hospital,  
Observatory 7925 
Tel: +27 (0)21 406 6315  
Fax: +27(0)86 611 0725 
Email: Christine.Rogers@uct.ac.za 
                             Lebogang.Ramma@uct.ac.za 
                                                                                                                       Internet: www.uct.ac.za 
 
 
Institution: University of Cape Town  
Title of the Study: Factors that influence the utilisation of ototoxicity monitoring 
programme 
MSc Student: Primrose Nhokwara 
 
 
I __________________________ have read (or had read to me by 
__________________) the Information Sheet. I understand what is required of me and I 
have had all my questions answered. I do not feel that I am forced to take part in this 
study and I am doing so of my own free will. I know that I can withdraw at any time if I 
so wish and that it will have no bad consequences for me. 
Signed: 
________________________________________          ___________________________ 
Participant       Date and place 
 
 
________________________________________           __________________________ 
Researcher       Date and place 
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Appendix G:  Draft Questionnaire 
 
Topic: Factors that influence the utilisation of ototoxicity monitoring programme 
Instructions: 
The following questions describe your experience at the clinic as a TB patient. Please 
select the appropriate response based on your experience. Please answer every question.  
If you are not sure, please choose the one that best matches your experience.  
   
 
  Strongly 
Agree 
Agree Disagree Strongly 
Disagree 
1 The taxi costs to the clinic stop me from attending my clinic appointments     
2 It takes long to travel to the clinic from home/work     
3 I am unable to take time off work every month in order to get my hearing 
tested 
    
4 I did not attend my clinic appointments because the TB pills make me very 
sick 
    
5 I know about the hearing tests done for people with TB     
6 I have had my hearing tested when I started taking TB pills     
7 People wait for long in the queue to get their hearing tested that is why I do 
not come 
    
8 My hearing is fine so I do not need to have it checked     
9 I do not hear as well as I used to     
10 The nurses have explained why I need to have my hearing tested     
11 The nurses at the clinic are helpful and friendly     
12 The nurses are concerned about me as a TB patient and give the care I need     
13 The nurses shout at me if I forget to take my TB pills     
14 Testing my hearing is not as important as taking my TB pills     
15 You cannot avoid losing your hearing  so I just have to accept it     
16 I am aware that TB pills can cause hearing loss     
17 Hearing loss is a sign of punishment from the ancestors     
18 I have a hearing loss because I was bewitched     
19 My family supports me in this time of illness     
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Appendix H: Final English Questionnaire 
 
                       
 
Topic: Factors that influence the utilisation of ototoxicity monitoring programme 
Instructions: 
The questions below ask about your experience at the clinic as a TB patient. Please select the response with 
a cross (X) based on your experience.    
1. Have you ever missed your hearing test appointment?     
 
2. Did you or would you miss your hearing test appointment because of any of the following reasons?:  
a). Taxi costs to the clinic?  
Strongly 
Agree 




b). Unable to take time off work?  
Strongly 
Agree 




c). TB medication making you very sick? 
Strongly 
Agree 




d). Long waiting queues? 
Strongly 
Agree 











Yes  No  
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  Strongly 
Agree 
Agree Disagree Strongly 
Disagree 
3. Do you think you only need to have your hearing tested if you feel 
deaf? 
    
4. Do you think testing your hearing is as important as taking your 
TB medication? 
    
5. Do you find the nurses rude that is why you do not come?     
6. Do you think the nurses at the clinic are helpful and friendly     
7. Do you think it is God’s will if you get a hearing loss?     
8. Do you think hearing loss is a sign of punishment from the 
ancestors? 
    
9. Do you think you have a hearing loss because you were 
bewitched? 
    
10. Do you think the hearing loss will go away when you finish your 
TB treatment? 
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Appendix I: Delphi Research Information Letter 
School of Health and Rehabilitation 
Sciences 
Faculty of Health Sciences 
Divisions of Communications Sciences and 
Disorders, Nursing and Midwifery, 
Occupational Therapy & Physiotherapy  
F45 Old Main Building,  
Groote Schuur Hospital,  
Observatory 7925 
Tel: +27(0)21 406 6315  
Fax: +27(0)86 611 0725 
Email: Christine.Rogers@uct.ac.za 
                      Lebogang.Ramma@uct.ac.za 




Title of the Study: Factors that influence the utilisation of ototoxicity monitoring 
programme 
 
Supervisor: Christine Rogers 
Co-Supervisor: Dr Lebogang Ramma 
MSc Student: Primrose Nhokwara 
Institution: University of Cape Town  
Introduction 
My name is Primrose Nhokwara. I am studying at the University of Cape Town. My 
supervisors are Christine Rogers and Dr Lebogang Ramma. For my study I want to find 
out what makes people come or not come for the hearing tests done at the Khayelitsha 
(Site B and C) community health clinic (CHC).  I would like to invite you to be part of 
this study. If you say yes, you need to read and understand what the study is about.  This 
letter will tell you what will happen. Please make sure you fully understand what is 
involved before you say yes. 
 
Ethical Approval: This clinical study protocol has been submitted to the University of 
Cape Town, Human Research Ethics Committee (HREC) and written ethical approval 
has been granted by that committee (HREC 604/2012).  
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Purpose of the Study:  
This clinic is able to test hearing when people are getting treated for TB.  We are trying 
to find out the reasons that make people come or not come for these tests. Since you are 
knowledgeable in the area of TB or have experience working with TB patients, we think 
you might be able to give us more insight as a health professional. Your opinion as a 
health professional will help us to ask he right questions thereby improve the current 
services provided. It will also help us when putting more of these services in other 
communities like this one. 
 
Study Procedure: 
You will be asked go through the questionnaire and write down what you think of the 
questions.  There will be space after each question for you to write your comments 
regarding your suggestions about the question. You will check if there are any changes 
that need to be made to it and if the language used is acceptable. It will take about 10 – 
15 minutes to go through the questionnaire.  
 
Benefits:  
There is unfortunately no immediate benefit for you, nor payment for having taken part in 
our research project. However, your participation will help us to improve delivering our 
services to you. The findings from this study will be presented to the Department of 
Health and the research participants via the notice board at the community clinic. The 
findings can also be emailed it to you as per your request. 
 
Risks: 
There are no risks associated in taking part in this study. The information that you will 
provide through the discussion and feedback on the questionnaire will help the 
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Costs:  
There are no costs expected. The feedback with your suggestions will be sent via email or 
physically collecting the hard copy from you.  
 
Confidentiality: 
Your privacy will be maintained during the study and when writing up the results. Any 
identifying information will be removed when storing the feedback from the 
questionnaires on an Excel spread sheet on a password protected computer. 
 
Voluntary Participation  
Taking part in this study is at will. If at any point you do not want to continue with the 
study, you have the right to do so and there will be no penalties for dropping out of the 
study. 
Questions: 
All questions related to this study can be forwarded to the following individuals: 
 
Primrose Nhokwara (Researcher)  
Cell: 073 827 6771                                                 Email: nhkpri001@myuct.ac.za 
Christine Rogers (Supervisor)  
Tel: 021 406 6315                                                 Email: christine.rogers@uct.ac.za 
Dr. Lebogang Ramma (Co-Supervisor)  
Tel: 021 406 6954   Cell: 073 153 3803                 Email: Lebogang.Ramma@uct.ac.za  
A/Prof. Mark Blockman (Chairperson)  
University of Cape Town, Faculty of Health Sciences, Human Research Ethics 
Committee                                                              Email:  Mark.Blockman@uct.ac.za 
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Appendix J: Flesch-Kincaid Analysis 
Reading Ease 
A higher score indicates easier readability; scores usually range between 0 and 100. 
Readability Formula Score 
Flesch-Kincaid Reading Ease  87.3 
Grade Levels 
A grade level (based on the USA education system) is equivalent to the number of years 
of education a person has had. Scores over 22 should generally be taken to mean graduate 
level text. 
Readability Formula Grade 
Flesch-Kincaid Grade Level  2.7 
Gunning-Fog Score  5 
Coleman-Liau Index  6.7 
SMOG Index  4.1 
Automated Readability Index  0 
Average Grade Level 3.7 
Text Statistics 
Character Count 793 
Syllable Count 276 
Word Count 207 
Sentence Count 31 
Characters per Word 3.8 
Syllables per Word 1.3 
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Appendix K: Translated (Xhosa) Questionnaire 
 
 
Igama lesifundo: Izizathu ezenza abantu basebenzise konke okwe ototoxicity monitoring 
programme 
Landela oku: 
Lemibibuzo ilandelayo ikubuza ngolwazinge Kliniki njengomntu one TB. Sicela 
uphendule ngokubala u “X”  kovumelana nayo.    
2. Wakhe waliphosa idinga lako lokuvavanya iindlebe? 
 
2. Ingaba izizathu ezenze uphose idinga lako zikhona kwezi zilandelayo? 
a). Imali yokukhwela uze eKliniki? 
Ndivuma 
kakulu 




b). Ukungakwazi ukuthetha ixesha emsebenzini? 
Ndivuma 
kakulu 




c). Amayeza e-TB ayakugulisa? 
Ndivuma 
kakulu 




d). Ixesha elide ulindile emgceni? 
Ndivuma 
kakulu 









Ewe  Hayi  
FACTORS INFLUENCING OTOTOXICITY MONITORING SERVICES            120 
 
  Ndiyavuma 
kakulu 
Ndiyavuma Andivumi Andivumi 
kakulu 
3. Ingaba ucinga kufuneka uyovavanya iindlebe zakho xa uziva 
zivaleka? 
    
4. Ingaba ucinga ukuvavanya iindlebe zako kubaluleke 
njengokuthatha amayeza wako e-TB? 
    
5. Ingaba isizathu esenza ungezi ngoo-mongikazi abangenabubele?     
6. Ingaba ucinga ukuba oo-mongikazi banobubele ngokuncedisana 
nawe? 
    
7. Ingaba ucinga ukuba kukwenza komdali ukuba uye waveleka 
iindlebe? 
    
8. Ingaba ucinga ukuba abaphantsi bayakuvalela xa kuvaleka 
iindlebe zakho? 
    
9. Ingaba ucinga ukuba uthakathiwe xa iindlebe zako zivalekile?     
10
. 
Ingaba ucinga ukuba zizokuvuleka iindlebe zakho xa uyigqibile 
uwathatha amayeza eTB? 















FACTORS INFLUENCING OTOTOXICITY MONITORING SERVICES            121 
 
Appendix L: City of Cape Town Approval 
 
